1
|
Lei J, Lü W, Wang W, Wang H, Guo X, Cheng P, Gong M, Liu L. [Comparison of the microbiota diversity between autogenous and anautogenous Culex pipiens pallens]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2024; 36:52-58. [PMID: 38604685 DOI: 10.16250/j.32.1374.2023204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/13/2024]
Abstract
OBJECTIVE To investigate the microbiota composition and diversity between autogenous and anautogenous Culex pipiens pallens, so as to provide insights into unraveling the pathogenesis of autogeny in Cx. pipiens pallens. METHODS Autogenous and anautogenous adult Cx. pipiens pallens samples were collected at 25 ℃, and the hypervariable regions of the microbial 16S ribosomal RNA (16S rRNA) gene was sequenced on the Illumina NovaSeq 6000 sequencing platform. The microbiota abundance and diversity were evaluated using the alpha diversity index, and the difference in the microbiota structure was examined using the beta diversity index. The microbiota with significant differences in the abundance between autogenous and anautogenous adult Cx. pipiens pallens samples was identified using the linear discriminant analysis effect size (LEfSe). RESULTS The microbiota in autogenous and anautogenous Cx. pipiens pallens samples belonged to 18 phyla, 28 classes, 70 orders, 113 families, and 170 genera, and the dominant phyla included Proteobacteria, Bacteroidetes, and so on. At the genus level, Wolbachia was a common dominant genus, and the relative abundance was (77.6 ± 11.3)% in autogenous Cx. pipiens pallens samples and (47.5 ± 8.5)% in anautogenous mosquito samples, while Faecalibaculum (0.4% ± 0.1%), Dubosiella (0.5% ± 0.0%) and Massilia (0.5% ± 0.1%) were specific species in autogenous Cx. pipiens pallens samples. Alpha diversity analysis showed that higher Chao1 index and ACE index in autogenous Cx. pipiens pallens samples than in anautogenous samples (both P values > 0.05), and lower Shannon index (P > 0.05) and Simpson index (P < 0.05) in autogenous Cx. pipiens pallens samples than in anautogenous samples. LEfSe analysis showed a total of 48 significantly different taxa between autogenous and anautogenous Cx. pipiens pallens samples (all P values < 0.05). CONCLUSIONS There is a significant difference in the microbiota diversity between autogenous and anautogenous Cx. pipiens pallens.
Collapse
Affiliation(s)
- J Lei
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - W Lü
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - W Wang
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - H Wang
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - X Guo
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - P Cheng
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - M Gong
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| | - L Liu
- Shandong Institute of Parasitic Diseases; Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China
| |
Collapse
|
2
|
Yang BJ, A XR, Mu XM, Cheng P, Zhou JW, Ma JD, Lyu YK. [Epidemiologic characteristics and drug resistance of isolated from blood culture escherichia coli in a hospital in Qinghai Province from 2016 to 2022]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:2102-2109. [PMID: 38186162 DOI: 10.3760/cma.j.cn112150-20230627-00492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Objective: To explore the drug resistance of Isolated From Blood Culture Escherichia coli (E. coli) in a hospital in Qinghai over the past seven years, to evaluate the ability of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to analyze the homologous origin of E. coli, and to establish a protein fingerprint library to match with it, adjuvant clinical experience medication so as to provide the basis for the prevention and control of hospital-acquired infections. Methods: Retrospective analysis of blood cultures sent to hospitals from January 2016 to December 2022. Drug resistance and resistance changes in E. coli.A total of 1 841 E. coli strains were isolated from Qinghai Provincial People's Hospital from January 2016 to December 2022; all strains were identified by MALDI-TOF MS, and the VITEK2.0 drug sensitivity analyzer was applied for drug sensitivity analysis of the strains, and the mass spectrometry homology analysis and self-constructed protein fingerprint library were carried out by MALDI-Biotyper software; the protein fingerprint library was built by using WHONET5.6 software was used to statistically analyze the drug sensitivity results, SPSS23.0 software was used to analyze the relationship between fingerprint typing and drug sensitivity, and the χ2 test was used for intergroup comparisons. Results: A total of 1 841 strains of E. coli were detected in 4 582 positive blood culture specimens from January 2016 to December 2022, with a detection rate of 40.17%; the resistance rate of E. coli from blood sources to piperacillin/tazobactam and ceftriaxone was on the rise, and it was slightly decreased to cefepime, amikacin, levofloxacin, and sulfamethoxazole, and there was not much change to the rest of the drugs; After MALDI-Biotyper clustering analysis, the 1841 E. coli strains from Isolated From Blood Culture were classified into two major clusters and five subtypes, of which type Ⅰa1 accounted for about 40%, type Ⅰa2 accounted for about 2.7%, type Ⅰb accounted for about 3.8, type Ⅱa accounted for about 46%, and type Ⅱb accounted for about 7.5%. The detection rate of type Ⅰa1 E. coli was higher in general surgery (50.45%) and emergency surgery (50.92%), and the detection rate of type Ⅰb E. coli was higher in emergency medicine(10.05%)than in other departments. The drug sensitivity results of different subtypes were compared with each other, the resistance rate of type Ⅰa1 E. coli to cefepime was 21.3% higher than that of the remaining four types, and the difference was statistically significant (χ2=37.74,P=0.000); the resistance rate of type Ⅱ E. coli(>60%) to sulfamethoxazole was higher than that of type Ⅰ (<60%) as a whole, and the difference was statistically significant (χ2=15.248,P=0.004); and a preliminary database of homologous protein fingerprints of E. coli has been established E. coli homologous protein fingerprint library and validated. The drug susceptibility results of 1 288 E. coli strains in the validation set were statistically analyzed and compared with those in the training set. There was no significant difference(P>0.05). Conclusion: In recent years, the resistance rate of E. coli isolated from a hospital in Qinghai province to piperacillin/Tazobactam, cefepime, amicacin and other antibiotics has changed greatly. A fingerprint database of E. coli homologous protein was established, and it was found that the drug sensitivity data of E. coli were different among different fingerprint types. According to drug sensitivity, drug use could assist clinical experience and provide evidence for prevention and control of hospital illness.
Collapse
Affiliation(s)
- B J Yang
- Medical College of Qinghai University, Xining 810001, China
| | - X R A
- Department of Medical Laboratory, Qinghai Provincial People's Hospital,Xining 810007, China
| | - X M Mu
- Department of Medical Laboratory, Qinghai Provincial People's Hospital,Xining 810007, China
| | - P Cheng
- Department of Medical Laboratory, Qinghai Provincial People's Hospital,Xining 810007, China
| | - J W Zhou
- Department of Medical Laboratory, Qinghai Provincial People's Hospital,Xining 810007, China
| | - J D Ma
- Department of Medical Laboratory, Qinghai Provincial People's Hospital,Xining 810007, China
| | - Y K Lyu
- Medical College of Qinghai University, Xining 810001, China
| |
Collapse
|
3
|
Huang W, Liu X, Cheng P, Li Y, Zhou H, Liu Y, Dong Y, Wang P, Xu C, Xu X. Prognostic value of plaque volume combined with CT fractional flow reserve in patients with suspected coronary artery disease. Clin Radiol 2023; 78:e1048-e1056. [PMID: 37788967 DOI: 10.1016/j.crad.2023.08.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 08/08/2023] [Accepted: 08/30/2023] [Indexed: 10/05/2023]
Abstract
AIM To investigate the prognostic value of quantitative plaque volume on coronary computed tomography (CT) angiography (CTA) combined with CT fractional flow reserve (CT-FFR) for major adverse cardiac events (MACE) in suspected coronary artery disease (CAD) patients. MATERIALS AND METHODS Patients who underwent coronary CTA with clinically suspected CAD were enrolled retrospectively in this study. Patients' baseline, Framingham Risk Score (FRS), coronary CTA plaque assessment, and CT-FFR were analysed retrospectively. Study outcomes included rehospitalisation and MACE (ST-segment elevation myocardial infarction, unstable angina, or non-ST-segment elevation myocardial infarction, revascularisation, and cardiac death). RESULTS There were 251 patients in the study, with a follow-up period of 1-6.58 years. Mean age was 61.16 ± 10.45 years and 146 (58%) patients were male. Higher CT-adapted Leaman score and quantitative plaque volume were found in patients with FRS >0.2 regardless of categorical or continuous variables. Coronary scores, quantitative plaque parameters, and CT-FFR were associated with MACE and rehospitalisation in univariate analysis. In model 1, CT-FFR was associated with MACE in multivariate Cox analysis when adjusted for FRS and CT-adapted Leaman score. Quantitative plaque parameters including calcified plaque volume, fibro-fatty plaque volume, low-attenuation plaque volume, non-calcified plaque volume, and total plaque volume were significantly associated with MACE and improved overall prognostic performance in a model adjusted for CT-FFR. CONCLUSION Additional quantitative plaque volume and CT-FFR further improve the predictive incremental value based on risk factor scores for prognostic prediction in patients. Adding quantitative plaque volume combined with CT-FFR analysis to anatomical and clinical assessment will be further beneficial to predict patients' prognosis of MACE.
Collapse
Affiliation(s)
- W Huang
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - X Liu
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - P Cheng
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - Y Li
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Jianghan District, Wuhan 430022, China
| | - H Zhou
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - Y Liu
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - Y Dong
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - P Wang
- Department of Clinical Laboratory, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China
| | - C Xu
- Key Laboratory of Molecular Biophysics of the Ministry of Education, Cardio-X Institute, College of Life Science and Technology and Center for Human Genome Research, Huazhong University of Science and Technology, 1037 Luoyu Road, Hongshan District, Wuhan 430070, China
| | - X Xu
- Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Yanhu Avenue, Wuchang District, Wuhan 430077, China.
| |
Collapse
|
4
|
Qian AM, Cheng R, Gu XY, Yin R, Bai RM, Du J, Sun MY, Cheng P, K Lee KLEE, Du LZ, Cao Y, Zhou WH, Zhao YY, Jiang SY. [Treatment of patent ductus arteriosus in very preterm infants in China]. Zhonghua Er Ke Za Zhi 2023; 61:896-901. [PMID: 37803856 DOI: 10.3760/cma.j.cn112140-20230706-00440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Abstract
Objective: To describe the current status and trends in the treatment of patent ductus arteriosus (PDA) among very preterm infants (VPI) admitted to the neonatal intensive care units (NICU) of the Chinese Neonatal Network (CHNN) from 2019 to 2021, and to compare the differences in PDA treatment among these units. Methods: This was a cross-sectional study based on the CHNN VPI cohort, all of 22 525 VPI (gestational age<32 weeks) admitted to 79 tertiary NICU within 3 days of age from 2019 to 2021 were included. The overall PDA treatment rates were calculated, as well as the rates of infants with different gestational ages (≤26, 27-28, 29-31 weeks), and pharmacological and surgical treatments were described. PDA was defined as those diagnosed by echocardiography during hospitalization. The PDA treatment rate was defined as the number of VPI who had received medication treatment and (or) surgical ligation of PDA divided by the number of all VPI. Logistic regression was used to investigate the changes in PDA treatment rates over the 3 years and the differences between gestational age groups. A multivariate Logistic regression model was constructed to compute the standardized ratio (SR) of PDA treatment across different units, to compare the rates after adjusting for population characteristics. Results: A total of 22 525 VPI were included in the study, with a gestational age of 30.0 (28.6, 31.0) weeks and birth weight of 1 310 (1 100, 1 540) g; 56.0% (12 615) of them were male. PDA was diagnosed by echocardiography in 49.7% (11 186/22 525) of all VPI, and the overall PDA treatment rate was 16.8% (3 795/22 525). Of 3 762 VPI who received medication treatment, the main first-line medication used was ibuprofen (93.4% (3 515/3 762)) and the postnatal day of first medication treatment was 6 (4, 10) days of age; 59.3% (2 231/3 762) of the VPI had been weaned from invasive respiratory support during the first medication treatment, and 82.2% (3 092/3 762) of the infants received only one course of medication treatment. A total of 143 VPI underwent surgery, which was conducted on 32 (22, 46) days of age. Over the 3 years from 2019 to 2021, there was no significant change in the PDA treatment rate in these VPI (P=0.650). The PDA treatment rate decreased with increasing gestational age (P<0.001). The PDA treatment rates for VPI with gestational age ≤26, 27-28, and 29-31 weeks were 39.6% (688/1 737), 25.9% (1 319/5 098), and 11.4% (1 788/15 690), respectively. There were 61 units having a total number of VPI≥100 cases, and their rates of PDA treatment were 0 (0/116)-47.4% (376/793). After adjusting for population characteristics, the range of standardized ratios for PDA treatment in the 61 units was 0 (95%CI 0-0.3) to 3.4 (95%CI 3.1-3.8). Conclusions: From 2019 to 2021, compared to the peers in developed countries, VPI in CHNN NICU had a different PDA treatment rate; specifically, the VPI with small birth gestational age had a lower treatment rate, while the VPI with large birth gestational age had a higher rate. There are significant differences in PDA treatment rates among different units.
Collapse
Affiliation(s)
- A M Qian
- Department of Neonatology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - R Cheng
- Department of Neonatology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - X Y Gu
- National Health Commission (NHC) Key Laboratory of Neonatal Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - R Yin
- Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - R M Bai
- Department of Neonatology, Northwest Women's and Children's Hospital, Xi'an 710061, China
| | - J Du
- Department of Neonatology, Beijing Children's Hospital, Capital Medical University, National Center of Children's Health, Beijing 100045, China
| | - M Y Sun
- Department of Neonatology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - P Cheng
- Department of Neonatology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, China
| | - K L E E K Lee
- the Maternal Infant Care Research Center (MiCARE), Mount Sinai Hospital, Toronto M5G 1X5, Canada
| | - L Z Du
- Department of Neonatology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310051, China
| | - Y Cao
- Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - W H Zhou
- Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - Y Y Zhao
- Department of Neonatology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - S Y Jiang
- Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| |
Collapse
|
5
|
Bowen RAR, Esguerra V, Arboleda E, Cheng P, Hu B. Impact of blood collection devices and mode of transportation on peripheral venous blood gas parameters. Clin Chim Acta 2023; 548:117464. [PMID: 37399883 DOI: 10.1016/j.cca.2023.117464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Revised: 06/05/2023] [Accepted: 06/28/2023] [Indexed: 07/05/2023]
Abstract
BACKGROUND Peripheral venous blood (PVB) gas analysis has become an alternative to arterial blood gas (BG) analysis in assessing acid-base balance. This study aimed to compare the effects of blood collection devices and modes of transportation on peripheral venous BG parameters. METHODS PVB-paired specimens were collected from 40 healthy volunteers into blood gas syringes (BGS) and blood collection tubes (BCT), transported by either a pneumatic tube system (PTS) or human courier (HC) to the clinical laboratory, and compared using a two-way ANOVA or Wilcoxon signed-rank test. To determine clinical significance, the PTS and HC-transported BGS and BCT biases were compared to the total allowable error (TEA). RESULTS PVB partial pressure of oxygen (pO2), fractional oxyhemoglobin (FO2Hb), fractional deoxyhemoglobin (FHHb), and oxygen saturation (sO2) showed statistically significant differences between BGS and BCT (p < 0.0001). Compared to HC-transported BGS and BCT, statistically significant increases in pO2, FO2Hb, sO2, oxygen content (only in BCT) (all p < 0.0001), and base excess extracellular (only in BCT; p < 0.0014) concentrations and a statistically significant decrease in FHHb concentration (p < 0.0001) were found in BGS and BCT delivered by PTS. The biases between PTS- and HC-transported BGS and BCT exceeded the TEA for many BG parameters. CONCLUSIONS Collecting PVB in BCT is unsuitable for pO2, sO2, FO2Hb, FHHb, and oxygen content determinations.
Collapse
Affiliation(s)
- Raffick A R Bowen
- Department of Pathology, Stanford Health Care, Stanford, CA 94305, United States.
| | - Vanessa Esguerra
- Stanford Hospital and Clinics, Stanford, CA 94305, United States
| | | | - Phil Cheng
- Stanford Hospital and Clinics, Stanford, CA 94305, United States
| | - Bing Hu
- Stanford Hospital and Clinics, Stanford, CA 94305, United States
| |
Collapse
|
6
|
Kraehenbuehl L, Schneider S, Pawlik L, Mangana J, Cheng P, Dummer R, Meier-Schiesser B. Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis. Pharmaceuticals (Basel) 2023; 16:935. [PMID: 37513847 PMCID: PMC10383648 DOI: 10.3390/ph16070935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Revised: 05/28/2023] [Accepted: 06/22/2023] [Indexed: 07/30/2023] Open
Abstract
Recent progress in the treatment of advanced melanoma has led to the improved survival of affected patients. However, novel treatments also lead to considerable and distinct skin toxicity. To further characterize cutaneous adverse events (AE) of systemic treatments, we conducted a single-center retrospective study of biopsy-proven cutaneous adverse events of melanoma treatment over a period of 10 years at the University Hospital of Zurich, Switzerland. In 102 identified patients, 135 individual skin AEs developed. Immune checkpoint blockade (ICB) was causal for 81 skin AEs, and 54 were related to targeted therapies (TT). Recorded types of skin AEs included lichenoid, maculopapular, acneiform, urticarial, panniculitis, folliculitis, psoriasiform, granulomatous, eczematous, and others. The incidence of skin AEs was higher with TT (18.54%) than with ICB (9.64%, p = 0.0029). Most AEs were low-grade, although 19.21% of AEs were common terminology criteria for adverse events (CTCAE) Grades 3 or 4. A large spectrum of skin AEs was documented during treatment of advanced melanoma, and distinct phenotypes were observed, depending on treatment classes. AEs occurred earlier during treatment with TT than with ICB, and distinct types of skin AEs were associated with respective treatment classes. This study comprehensively describes skin AEs occurring during systemic treatment for melanoma at a single center.
Collapse
Affiliation(s)
- Lukas Kraehenbuehl
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Stephanie Schneider
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Laura Pawlik
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Joanna Mangana
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Reinhard Dummer
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| | - Barbara Meier-Schiesser
- Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), 8091 Zurich, Switzerland
| |
Collapse
|
7
|
Cerminara SE, Cheng P, Kostner L, Huber S, Kunz M, Maul JT, Böhm JS, Dettwiler CF, Geser A, Jakopović C, Stoffel LM, Peter JK, Levesque M, Navarini AA, Maul LV. Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? Eur J Cancer 2023; 190:112954. [PMID: 37453242 DOI: 10.1016/j.ejca.2023.112954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 06/13/2023] [Accepted: 06/17/2023] [Indexed: 07/18/2023]
Abstract
BACKGROUND Convolutional neural networks (CNNs) have outperformed dermatologists in classifying pigmented skin lesions under artificial conditions. We investigated, for the first time, the performance of three-dimensional (3D) and two-dimensional (2D) CNNs and dermatologists in the early detection of melanoma in a real-world setting. METHODS In this prospective study, 1690 melanocytic lesions in 143 patients with high-risk criteria for melanoma were evaluated by dermatologists, 2D-FotoFinder-ATBM and 3D-Vectra WB360 total body photography (TBP). Excision was based on the dermatologists' dichotomous decision, an elevated CNN risk score (study-specific malignancy cut-off: FotoFinder >0.5, Vectra >5.0) and/or the second dermatologist's assessment with CNN support. The diagnostic accuracy of the 2D and 3D CNN classification was compared with that of the dermatologists and the augmented intelligence based on histopathology and dermatologists' assessment. Secondary end-points included reproducibility of risk scores and naevus counts per patient by medical staff (gold standard) compared to automated 3D and 2D TBP CNN counts. RESULTS The sensitivity, specificity, and receiver operating characteristics area under the curve (ROC-AUC) for risk-score-assessments compared to histopathology of 3D-CNN with 95% confidence intervals (CI) were 90.0%, 64.6% and 0.92 (CI 0.85-1.00), respectively. While dermatologists and augmented intelligence achieved the same sensitivity (90%) and comparable classification ROC-AUC (0.91 [CI 0.80-1.00], 0.88 [CI 0.77-1.00]) with 3D-CNN, their specificity was superior (92.3% and 86.2%, respectively). The 2D-CNN (sensitivity: 70%, specificity: 40%, ROC-AUC: 0.68 [CI 0.46-0.90]) was outperformed by 3D CNN and dermatologists. The 3D-CNN showed a higher correlation coefficient for repeated measurements of 246 lesions (R = 0.89) than the 2D-CNN (R = 0.79). The mean naevus count per patient varied significantly (gold standard: 210 lesions; 3D-CNN: 469; 2D-CNN: 1324; p < 0.0001). CONCLUSIONS Our study emphasises the importance of validating the classification of CNNs in real life. The novel 3D-CNN device outperformed the 2D-CNN and achieved comparable sensitivity with dermatologists. The low specificity of CNNs and the lack of automated counting of TBP nevi currently limit the use of augmented intelligence in clinical practice.
Collapse
Affiliation(s)
- Sara E Cerminara
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
| | - Lisa Kostner
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Stephanie Huber
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Michael Kunz
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Julia-Tatjana Maul
- Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland
| | - Jette S Böhm
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Chiara F Dettwiler
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Anna Geser
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Cécile Jakopović
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Livia M Stoffel
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Jelissa K Peter
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Mitchell Levesque
- Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
| | | | - Lara Valeska Maul
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
| |
Collapse
|
8
|
Huynh L, Hu B, Cheng P, Bowen RAR. Sporadically low chemistry test results due to fluid malfunction. Clin Chim Acta 2023; 544:117357. [PMID: 37105453 DOI: 10.1016/j.cca.2023.117357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 04/13/2023] [Accepted: 04/14/2023] [Indexed: 04/29/2023]
Affiliation(s)
- Lap Huynh
- Department of Pathology, Stanford University, Stanford, CA 94305
| | - Bing Hu
- Stanford Hospital and Clinics, Stanford, CA 94305
| | - Phil Cheng
- Stanford Hospital and Clinics, Stanford, CA 94305
| | | |
Collapse
|
9
|
Yeung PSW, Miller P, Lai-Nyugen TB, Cheng P, Ibrahim A, Shi RZ, Bowen RA, Luo RY. Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring. J Mass Spectrom Adv Clin Lab 2023; 28:99-104. [PMID: 36937810 PMCID: PMC10014293 DOI: 10.1016/j.jmsacl.2023.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 03/03/2023] [Accepted: 03/05/2023] [Indexed: 03/09/2023] Open
Abstract
Introduction Therapeutic drug monitoring (TDM) of immunosuppressants is essential for optimal care of transplant patients. Immunoassays and liquid chromatography-mass spectrometry (LC-MS) are the most commonly used methods for TDM. However, immunoassays can suffer from interference from heterophile antibodies and structurally similar drugs and metabolites. Additionally, nominal-mass LC-MS assays can be difficult to optimize and are limited in the number of detectable compounds. Objectives The aim of this study was to implement a mass spectrometry-based test for immunosuppressant TDM using online solid-phase extraction (SPE) and accurate-mass full scan-single ion monitoring (FS-SIM) data acquisition mode. Methods LC-MS analysis was performed on a TLX-2 multi-channel HPLC with a Q-Exactive Plus mass spectrometer. TurboFlow online SPE was used for sample clean up. The accurate-mass MS was set to positive electrospray ionization mode with FS-SIM for quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A. MS2 fragmentation pattern was used for compound confirmation. Results The method was validated in terms of precision, analytical bias, limit of quantitation, linearity, carryover, sample stability, and interference. Quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A correlated well with results from an independent reference laboratory (r = 0.926-0.984). Conclusions Accurate-mass FS-SIM can be successfully utilized for immunosuppressant TDM with good correlation with results generated by standard methods. TurboFlow online SPE allows for a simple "protein crash and shoot" sample preparation protocol. Compared to traditional MRM, analyte quantitation by FS-SIM facilitates a streamlined assay optimization process.
Collapse
Key Words
- Accurate-mass
- CAP, College of American Pathologists
- CLSI, Clinical & Laboratory Standards Institute
- CV, coefficient of variation
- ESI, electrospray ionization
- FS-SIM, full scan-single ion monitoring
- Full scan single-ion monitoring
- HCD, high-energy C-trap dissociation
- IRB, Institutional Review Board
- Immunosuppressive drugs
- LC-MS, liquid chromatography-mass spectrometry
- LDT, laboratory developed test
- MRM, multiple reaction monitoring
- Mass spectrometry
- Online solid-phase extraction
- SD, standard deviation
- SPE, solid-phase extraction
- TDM, therapeutic drug monitoring
- Therapeutic drug monitoring
Collapse
Affiliation(s)
- Priscilla S.-W. Yeung
- Department of Pathology, Stanford University, Stanford, CA, USA
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | - Paige Miller
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | | | - Phil Cheng
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | - Amira Ibrahim
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | - Run-Zhang Shi
- Department of Pathology, Stanford University, Stanford, CA, USA
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | - Raffick A.R. Bowen
- Department of Pathology, Stanford University, Stanford, CA, USA
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
| | - Ruben Yiqi Luo
- Department of Pathology, Stanford University, Stanford, CA, USA
- Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA
- Corresponding author at: 3375 Hillview Ave, Palo Alto, CA 94304, USA.
| |
Collapse
|
10
|
Cheng P, A XR, Mu XM, Yang BJ, Chan SS. [Correlation of extracellular enzymes activity of Candida glabrata clinical isolates with in vivo pathogenicity in Galleria mellonella larvae]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:229-235. [PMID: 36797581 DOI: 10.3760/cma.j.cn112150-20220712-00709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Objective: To explore the relationship between extracellular enzymes activity and virulence of Candida glabrata clinical isolates based on the infection model of Galleria mellonella larvae. Methods: Using experimental research methods, 71 strains of non-repetitive Candida glabrata were collected from Qinghai Provincial People's Hospital from June 2021 to January 2022. Bovine serum protein agar medium, egg yolk agar medium, sheep blood agar medium, Tween-80 agar medium and triglyceride agar medium were used to detect the aspartyl protease activity, phospholipase activity, hemolysis activity, esterase activity and lipase activity of Candida glabrata. Median lethal concentration (LC50) was calculated by using 1.25×108 CFU/ml,2.50×108 CFU/ml,3.75×108 CFU/ml,5.00×108 CFU/ml suspension of Candida glabrata ATCC2001 to infect Galleria mellonella larvae. Histopathological and etiological analysis was performed to determine whether the infection model was successfully established. The clinical isolates of Candida glabrata were configured to infect Galleria mellonella larvae with LC50 concentration to detect the pathogenicity of Galleria mellonella larvae.Spearman test or Pearson test were used to analyze the correlation between the extracellular enzyme activity of Candida glabrata clinical isolates and the pathogenicity of Galleria mellonella larvae. Results: 71 strains of Candida glabrata isolated clinically were detected to have low hemolytic activity after 2 days of culture. Aspartyl protease was detected after 4 days of culture, among which 7 strains (9.86%), 19 strains (26.76%) and 45 strains (63.38%) showed low, medium and high aspartyl protease activity. After 7 days of culture, 71 strains did not detect phospholipase, esterase and lipase activities. Candida glabrata on Galleria mellonella larvae of LC50=2.5×108 CFU/ml Fungal spore were found in the intestinal tissue pathological section of Galleria mellonella larvae in the experimental group, and Candida glabrata was identified by the microbial Mass Spectrometry after culture, while no fungi were found in the pathological section and culture of the control group. Spearman test shows that, there was a linear positive correlation between aspartyl protease activity and the survival rate of Galleria mellonella larvae (r = 0.73, P<0.01), the difference was statistically significant.Pearson test shows that, there was no significant linear relationship between hemolytic activity and survival rate of Galleria mellonella larvae (r = 0.16, P = 0.34), the difference was not statistically significant. Conclusion: The clinical isolates of Candida glabrata in this study had aspartyl protease activity and low hemolytic activity, but no phospholipase, esterase and lipase activity. The activity of aspartyl aspartyl protease of Candida glabrata was positively correlated with the pathogenicity of Galleria mellonella larvae.
Collapse
Affiliation(s)
- P Cheng
- Medical College of Qinghai University, Xining 810001, China Department of Medical Laboratory, Qinghai Provincial People's Hospital, Xining 810007, China
| | - X R A
- Department of Medical Laboratory, Qinghai Provincial People's Hospital, Xining 810007, China
| | - X M Mu
- Department of Medical Laboratory, Qinghai Provincial People's Hospital, Xining 810007, China
| | - B J Yang
- Medical College of Qinghai University, Xining 810001, China
| | - S S Chan
- Department of Pathology, Qinghai Provincial People's Hospital, Xining 810007, China
| |
Collapse
|
11
|
Nadeau SA, Vaughan TG, Beckmann C, Topolsky I, Chen C, Hodcroft E, Schär T, Nissen I, Santacroce N, Burcklen E, Ferreira P, Jablonski KP, Posada-Céspedes S, Capece V, Seidel S, Santamaria de Souza N, Martinez-Gomez JM, Cheng P, Bosshard PP, Levesque MP, Kufner V, Schmutz S, Zaheri M, Huber M, Trkola A, Cordey S, Laubscher F, Gonçalves AR, Aeby S, Pillonel T, Jacot D, Bertelli C, Greub G, Leuzinger K, Stange M, Mari A, Roloff T, Seth-Smith H, Hirsch HH, Egli A, Redondo M, Kobel O, Noppen C, du Plessis L, Beerenwinkel N, Neher RA, Beisel C, Stadler T. Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. Sci Transl Med 2023; 15:eabn7979. [PMID: 36346321 PMCID: PMC9765449 DOI: 10.1126/scitranslmed.abn7979] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Genome sequences from evolving infectious pathogens allow quantification of case introductions and local transmission dynamics. We sequenced 11,357 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from Switzerland in 2020-the sixth largest effort globally. Using a representative subset of these data, we estimated viral introductions to Switzerland and their persistence over the course of 2020. We contrasted these estimates with simple null models representing the absence of certain public health measures. We show that Switzerland's border closures decoupled case introductions from incidence in neighboring countries. Under a simple model, we estimate an 86 to 98% reduction in introductions during Switzerland's strictest border closures. Furthermore, the Swiss 2020 partial lockdown roughly halved the time for sampled introductions to die out. Last, we quantified local transmission dynamics once introductions into Switzerland occurred using a phylodynamic model. We found that transmission slowed 35 to 63% upon outbreak detection in summer 2020 but not in fall. This finding may indicate successful contact tracing over summer before overburdening in fall. The study highlights the added value of genome sequencing data for understanding transmission dynamics.
Collapse
Affiliation(s)
- Sarah A. Nadeau
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Corresponding author. (T.S.); (S.A.N.)
| | - Timothy G. Vaughan
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | | | - Ivan Topolsky
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Chaoran Chen
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Emma Hodcroft
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Institute for Social and Preventive Medicine, University of Bern; 3012, Bern, Switzerland
| | - Tobias Schär
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Ina Nissen
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Natascha Santacroce
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Elodie Burcklen
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Pedro Ferreira
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Kim Philipp Jablonski
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Susana Posada-Céspedes
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Vincenzo Capece
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Sophie Seidel
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | | | - Julia M. Martinez-Gomez
- Department of Dermatology, University Hospital Zurich, University of Zurich; 8091, Zurich, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital Zurich, University of Zurich; 8091, Zurich, Switzerland
| | - Philipp P. Bosshard
- Department of Dermatology, University Hospital Zurich, University of Zurich; 8091, Zurich, Switzerland
| | - Mitchell P. Levesque
- Department of Dermatology, University Hospital Zurich, University of Zurich; 8091, Zurich, Switzerland
| | - Verena Kufner
- Institute of Medical Virology, University of Zurich; 8057, Zurich, Switzerland
| | - Stefan Schmutz
- Institute of Medical Virology, University of Zurich; 8057, Zurich, Switzerland
| | - Maryam Zaheri
- Institute of Medical Virology, University of Zurich; 8057, Zurich, Switzerland
| | - Michael Huber
- Institute of Medical Virology, University of Zurich; 8057, Zurich, Switzerland
| | - Alexandra Trkola
- Institute of Medical Virology, University of Zurich; 8057, Zurich, Switzerland
| | - Samuel Cordey
- Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals & Faculty of Medicine; 1205, Geneva, Switzerland
| | - Florian Laubscher
- Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals & Faculty of Medicine; 1205, Geneva, Switzerland
| | - Ana Rita Gonçalves
- Swiss National Reference Centre for Influenza, University Hospitals of Geneva; 1205, Geneva, Switzerland
| | - Sébastien Aeby
- Institute of Microbiology, University Hospital Centre and University of Lausanne; 1011, Lausanne, Switzerland
| | - Trestan Pillonel
- Institute of Microbiology, University Hospital Centre and University of Lausanne; 1011, Lausanne, Switzerland
| | - Damien Jacot
- Institute of Microbiology, University Hospital Centre and University of Lausanne; 1011, Lausanne, Switzerland
| | - Claire Bertelli
- Institute of Microbiology, University Hospital Centre and University of Lausanne; 1011, Lausanne, Switzerland
| | - Gilbert Greub
- Institute of Microbiology, University Hospital Centre and University of Lausanne; 1011, Lausanne, Switzerland
| | - Karoline Leuzinger
- Division of Clinical Virology, University Hospital Basel; 4051, Basel, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland
| | - Madlen Stange
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel; 4031, Basel, Switzerland
| | - Alfredo Mari
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel; 4031, Basel, Switzerland
| | - Tim Roloff
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel; 4031, Basel, Switzerland
| | - Helena Seth-Smith
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel; 4031, Basel, Switzerland
| | - Hans H. Hirsch
- Division of Clinical Virology, University Hospital Basel; 4051, Basel, Switzerland.,Department of Biomedicine, University of Basel; 4031, Basel, Switzerland
| | - Adrian Egli
- Department of Biomedicine, University of Basel; 4031, Basel, Switzerland.,Division of Clinical Bacteriology and Mycology, University Hospital Basel; 4031, Basel, Switzerland
| | | | | | | | - Louis du Plessis
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Niko Beerenwinkel
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland
| | - Richard A. Neher
- SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Biozentrum, University of Basel; 4056, Basel, Switzerland
| | - Christian Beisel
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland
| | - Tanja Stadler
- Department of Biosystems Science and Engineering, ETH Zurich; 4058, Basel, Switzerland.,SIB Swiss Institute of Bioinformatics; 1015, Lausanne, Switzerland.,Corresponding author. (T.S.); (S.A.N.)
| |
Collapse
|
12
|
Cheng P, Casement M, Kalmbach D, Castelan AC, Drake C. Digital Cognitive Behavioral Therapy for Insomnia Promotes Resilience During the Coronavirus Disease 19 (COVID-19) Pandemic. Sleep Med 2022. [PMCID: PMC9300228 DOI: 10.1016/j.sleep.2022.05.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
13
|
Luo H, Gao H, Zhang T, Cheng P. [A case of metastatic von Hippel Lindau-pancreatic neuroendocrine tumor]. Zhonghua Zhong Liu Za Zhi 2022; 44:1233-1234. [PMID: 36380674 DOI: 10.3760/cma.j.cn112152-20210611-00445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- H Luo
- Department of Oncology, the General Hospital of Western Theater Command, Chengdu 610083, China
| | - H Gao
- Department of Oncology, the General Hospital of Western Theater Command, Chengdu 610083, China
| | - T Zhang
- Department of Oncology, the General Hospital of Western Theater Command, Chengdu 610083, China
| | - P Cheng
- Department of Oncology, the General Hospital of Western Theater Command, Chengdu 610083, China
| |
Collapse
|
14
|
Dimitriou F, Hassel J, Orloff M, Hughes I, Kapiteijn E, Mehmi I, Montazeri K, Johnson D, Grover P, Gerard C, Simeone E, Gaudy Marqueste C, Cheng P, Long G, Carvajal R, Dummer R. 832P Treatment sequence with tebentafusp (tebe) and anti-PD1/ipilimumab (PD1+IPI) in HLA-A2*02:01 patients (pts) with metastatic uveal melanoma (mUM). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
15
|
Baker SA, Wong LK, Wieland R, Bulterys P, Allard L, Nguyen L, Quach T, Nguyen A, Chaesuh E, Cheng P, Bowen R, Virk M. Validated transport conditions maintain the quality of washed red blood cells. Transfusion 2022; 62:1860-1870. [DOI: 10.1111/trf.17062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Revised: 07/07/2022] [Accepted: 07/15/2022] [Indexed: 11/26/2022]
Affiliation(s)
- Steven Andrew Baker
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
- Transfusion Medicine Section, Department of Pathology University of Utah Salt Lake City Utah USA
| | - Lisa Kanata Wong
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
| | - Rebekah Wieland
- Department of Pathology Stanford University Stanford California USA
| | - Philip Bulterys
- Department of Pathology Stanford University Stanford California USA
| | - Libby Allard
- Department of Pathology Stanford University Stanford California USA
| | - Lang Nguyen
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
| | - Thinh Quach
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
| | - AnhThu Nguyen
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
| | - Eunkyong Chaesuh
- Division of Clinical Chemistry, Department of Pathology Stanford University Stanford California USA
| | - Phil Cheng
- Division of Clinical Chemistry, Department of Pathology Stanford University Stanford California USA
| | - Raffick Bowen
- Division of Clinical Chemistry, Department of Pathology Stanford University Stanford California USA
| | - Mrigender Virk
- Division of Transfusion Medicine, Department of Pathology Stanford University Stanford California USA
| |
Collapse
|
16
|
Bowen RAR, Esguerra V, Walker M, Cheng P, Nguyen T. Impact of recentrifugation of blood collection tubes on chemistry and immunochemistry analytes after 24 and 72 hours of refrigerated storage on the Roche Cobas 8000 platform. Clin Chim Acta 2022; 531:342-351. [PMID: 35513039 DOI: 10.1016/j.cca.2022.04.1002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 04/24/2022] [Accepted: 04/27/2022] [Indexed: 11/03/2022]
Abstract
BACKGROUND We discovered that blood collection tubes (BCTs) were inadvertently recentrifuged due to improper placement on our automated preanalytical system. This study was undertaken to determine the impact of recentrifugation of blood specimens collected in serum separator (SSTs) and plasma separator (PSTs) tubes after refrigerated storage for 24 and 72 h on the concentrations of chemistry and immunochemistry analytes. METHODS Blood was collected from 20 volunteers in SSTs and PSTs, centrifuged, and 36 chemistry and 14 immunochemistry analytes were measured at baseline in single-centrifuged tubes on a Roche Cobas 8000 chemistry platform. After baseline testing, the BCTs were refrigerated for 24 or 72 h, recentrifuged and retested. The results were compared to the single-centrifuged tubes for statistical significance. RESULTS Recentrifugation of BCTs after 24 or 72 h of refrigerated storage showed statistically significant increases in lactate dehydrogenase activity and potassium concentration and statistically significant decreases in glucose (except in SSTs after 24 h of refrigerated storage) and CO2 concentration, but no significant differences in immunochemistry analyte concentrations. CONCLUSION It may be safe to report most routine chemistry and immunochemistry analyte concentrations from recentrifuged SSTs and PSTs on the Roche Cobas 8000, which may save time and costs associated with recollection and retesting.
Collapse
Affiliation(s)
- Raffick A R Bowen
- Department of Pathology, Stanford University. Stanford, CA 94305, USA.
| | - Vanessa Esguerra
- Stanford University Medical Center: Stanford Hospital and Clinics, Stanford, CA 94305, USA
| | - Maria Walker
- Stanford University Medical Center: Stanford Hospital and Clinics, Stanford, CA 94305, USA
| | - Phil Cheng
- Stanford University Medical Center: Stanford Hospital and Clinics, Stanford, CA 94305, USA
| | - Thanh Nguyen
- Stanford University Medical Center: Stanford Hospital and Clinics, Stanford, CA 94305, USA
| |
Collapse
|
17
|
Ware J, Boughton CK, Allen JM, Wilinska ME, Tauschmann M, Denvir L, Thankamony A, Campbell FM, Wadwa RP, Buckingham BA, Davis N, DiMeglio LA, Mauras N, Besser REJ, Ghatak A, Weinzimer SA, Hood KK, Fox DS, Kanapka L, Kollman C, Sibayan J, Beck RW, Hovorka R, Hovorka R, Acerini CL, Thankamony A, Allen JM, Boughton CK, Dovc K, Dunger DB, Ware J, Musolino G, Tauschmann M, Wilinska ME, Hayes JF, Hartnell S, Slegtenhorst S, Ruan Y, Haydock M, Mangat J, Denvir L, Kanthagnany SK, Law J, Randell T, Sachdev P, Saxton M, Coupe A, Stafford S, Ball A, Keeton R, Cresswell R, Crate L, Cripps H, Fazackerley H, Looby L, Navarra H, Saddington C, Smith V, Verhoeven V, Bratt S, Khan N, Moyes L, Sandhu K, West C, Wadwa RP, Alonso G, Forlenza G, Slover R, Towers L, Berget C, Coakley A, Escobar E, Jost E, Lange S, Messer L, Thivener K, Campbell FM, Yong J, Metcalfe E, Allen M, Ambler S, Waheed S, Exall J, Tulip J, Buckingham BA, Ekhlaspour L, Maahs D, Norlander L, Jacobson T, Twon M, Weir C, Leverenz B, Keller J, Davis N, Kumaran A, Trevelyan N, Dewar H, Price G, Crouch G, Ensom R, Haskell L, Lueddeke LM, Mauras N, Benson M, Bird K, Englert K, Permuy J, Ponthieux K, Marrero-Hernandez J, DiMeglio LA, Ismail H, Jolivette H, Sanchez J, Woerner S, Kirchner M, Mullen M, Tebbe M, Besser REJ, Basu S, London R, Makaya T, Ryan F, Megson C, Bowen-Morris J, Haest J, Law R, Stamford I, Ghatak A, Deakin M, Phelan K, Thornborough K, Shakeshaft J, Weinzimer SA, Cengiz E, Sherr JL, Van Name M, Weyman K, Carria L, Steffen A, Zgorski M, Sibayan J, Beck RW, Borgman S, Davis J, Rusnak J, Hellman A, Cheng P, Kanapka L, Kollman C, McCarthy C, Chalasani S, Hood KK, Hanes S, Viana J, Lanning M, Fox DS, Arreaza-Rubin G, Eggerman T, Green N, Janicek R, Gabrielson D, Belle SH, Castle J, Green J, Legault L, Willi SM, Wysham C. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health 2022; 4:e245-e255. [PMID: 35272971 DOI: 10.1016/s2589-7500(22)00020-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Revised: 12/10/2021] [Accepted: 01/25/2022] [Indexed: 02/07/2023]
Abstract
BACKGROUND Closed-loop insulin delivery systems have the potential to address suboptimal glucose control in children and adolescents with type 1 diabetes. We compared safety and efficacy of the Cambridge hybrid closed-loop algorithm with usual care over 6 months in this population. METHODS In a multicentre, multinational, parallel randomised controlled trial, participants aged 6-18 years using insulin pump therapy were recruited at seven UK and five US paediatric diabetes centres. Key inclusion criteria were diagnosis of type 1 diabetes for at least 12 months, insulin pump therapy for at least 3 months, and screening HbA1c levels between 53 and 86 mmol/mol (7·0-10·0%). Using block randomisation and central randomisation software, we randomly assigned participants to either closed-loop insulin delivery (closed-loop group) or to usual care with insulin pump therapy (control group) for 6 months. Randomisation was stratified at each centre by local baseline HbA1c. The Cambridge closed-loop algorithm running on a smartphone was used with either (1) a modified Medtronic 640G pump, Medtronic Guardian 3 sensor, and Medtronic prototype phone enclosure (FlorenceM configuration), or (2) a Sooil Dana RS pump and Dexcom G6 sensor (CamAPS FX configuration). The primary endpoint was change in HbA1c at 6 months combining data from both configurations. The primary analysis was done in all randomised patients (intention to treat). Trial registration ClinicalTrials.gov, NCT02925299. FINDINGS Of 147 people initially screened, 133 participants (mean age 13·0 years [SD 2·8]; 57% female, 43% male) were randomly assigned to either the closed-loop group (n=65) or the control group (n=68). Mean baseline HbA1c was 8·2% (SD 0·7) in the closed-loop group and 8·3% (0·7) in the control group. At 6 months, HbA1c was lower in the closed-loop group than in the control group (between-group difference -3·5 mmol/mol (95% CI -6·5 to -0·5 [-0·32 percentage points, -0·59 to -0·04]; p=0·023). Closed-loop usage was low with FlorenceM due to failing phone enclosures (median 40% [IQR 26-53]), but consistently high with CamAPS FX (93% [88-96]), impacting efficacy. A total of 155 adverse events occurred after randomisation (67 in the closed-loop group, 88 in the control group), including seven severe hypoglycaemia events (four in the closed-loop group, three in the control group), two diabetic ketoacidosis events (both in the closed-loop group), and two non-treatment-related serious adverse events. There were 23 reportable hyperglycaemia events (11 in the closed-loop group, 12 in the control group), which did not meet criteria for diabetic ketoacidosis. INTERPRETATION The Cambridge hybrid closed-loop algorithm had an acceptable safety profile, and improved glycaemic control in children and adolescents with type 1 diabetes. To ensure optimal efficacy of the closed-loop system, usage needs to be consistently high, as demonstrated with CamAPS FX. FUNDING National Institute of Diabetes and Digestive and Kidney Diseases.
Collapse
|
18
|
Amweg A, Tusup M, Cheng P, Picardi E, Dummer R, Levesque MP, French LE, Guenova E, Läuchli S, Kundig T, Mellett M, Pascolo S. The A to I editing landscape in melanoma and its relation to clinical outcome. RNA Biol 2022; 19:996-1006. [PMID: 35993275 PMCID: PMC9415457 DOI: 10.1080/15476286.2022.2110390] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
RNA editing refers to non-transient RNA modifications that occur after transcription and prior to translation by the ribosomes. RNA editing is more widespread in cancer cells than in non-transformed cells and is associated with tumorigenesis of various cancer tissues. However, RNA editing can also generate neo-antigens that expose tumour cells to host immunosurveillance. Global RNA editing in melanoma and its relevance to clinical outcome currently remain poorly characterized. The present study compared RNA editing as well as gene expression in tumour cell lines from melanoma patients of short or long metastasis-free survival, patients relapsing or not after immuno- and targeted therapy and tumours harbouring BRAF or NRAS mutations. Overall, our results showed that NTRK gene expression can be a marker of resistance to BRAF and MEK inhibition and gives some insights of candidate genes as potential biomarkers. In addition, this study revealed an increase in Adenosine-to-Inosine editing in Alu regions and in non-repetitive regions, including the hyperediting of the MOK and DZIP3 genes in relapsed tumour samples during targeted therapy and of the ZBTB11 gene in NRAS mutated melanoma cells. Therefore, RNA editing could be a promising tool for identifying predictive markers, tumour neoantigens and targetable pathways that could help in preventing relapses during immuno- or targeted therapies.
Collapse
Affiliation(s)
- Austeja Amweg
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Marina Tusup
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Ernesto Picardi
- Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari "A. Moro", Bari, Italy.,Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council, Bari, Italy
| | - Reinhard Dummer
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Mitchell P Levesque
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Lars E French
- Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.,Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Emmanuella Guenova
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland.,Department of Dermatology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
| | - Severin Läuchli
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Thomas Kundig
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Mark Mellett
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| | - Steve Pascolo
- Department of Dermatology, University Hospital Zürich (USZ), Zürich, Switzerland.,Faculty of Medicine, University of Zürich (UZH), Zürich, Switzerland
| |
Collapse
|
19
|
Huang SB, Hu ZC, Zhang Y, Tang B, Wang P, Xu HL, Wang ZY, Dong YX, Cheng P, Rong YC, Wu J, Zhu JY. [Effects and mechanisms of allogeneic epidermal stem cells on the survival of allogeneic full-thickness skin grafts in nude mice with full-thickness skin defect wounds]. Zhonghua Shao Shang Za Zhi 2021; 37:1061-1069. [PMID: 34794258 DOI: 10.3760/cma.j.cn501120-20200704-00339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effects and mechanisms of allogeneic epidermal stem cells (ESCs) on the survival of allogeneic full-thickness skin grafts in nude mice with full-thickness skin defect wounds. Methods: Experimental research methods were applied. Primary ESCs that appeared paving stone-like after being cultured for 7 d were obtained by enzymatic digestion method from one 4-week-old male BALB/c-NU nude mouse (the same strain, age, and sex below). The cells of third passage were identified by flow cytometry to positively express ESC marker CD44 and negatively express CD45, meanwhile, the positive expression of ESC markers of p63 and integrin 6α, and negative expression of CD71 were identified by immunofluorescence method. The ESCs of third passage in the logarithmic growth phase were used for the following experiments. Twenty-six nude mice were equally divided into phosphate buffered saline (PBS) group and ESCs group according to the random number table. A full-thickness skin defect wound was made on the back of each nude mouse, and then the wounds of the two groups were sprayed with equal volumes of PBS and ESCs, respectively. The wounds were transplanted with full-thickness skin grafts cut from the backs of 4 other nude mice. Each ten nude mice from the two groups were selected, the wound healing and skin survival on post surgery day (PSD) 0 (immediately), 3, 7, 14, and 21 were observed, and the survival ratio and shrinkage rate of skin grafts on PSD 3, 7, 14, and 21 were calculated (the number of sample was the number of surviving skin grafts at each time point); the blood perfusion in the skin grafts on PSD 3, 7, and 14 was detected by the laser speckle blood flow imager, and the blood flow ratio of nude mice skin grafts in ESCs group to PBS group at each time point was calculated (the number of sample was the pair number of surviving skin grafts in group pairing at each time point). The skin graft tissue of each 3 nude mice remained in the two groups were collected on PSD 7, and the mRNA expressions and protein expressions of tumor necrosis factor α (TNF-α), interleukin 8 (IL-8), IL-10, type Ⅰ collagen, type Ⅲ collagen, and matrix metalloproteinase 9 (MMP-9) in the tissue were detected by real-time fluorescent quantitative reverse transcription polymerase chain reaction and Western blotting, respectively. Data were statistically analyzed with Log-rank test, analysis of variance for repeated measurement, one-way analysis of variance, independent sample t test, and Bonferroni correction. Results: Taking the condition on PSD 0 as a reference, the wounds of nude mice in the two groups healed gradually on PSD 3, 7, 14, and 21, and the shrinkage of skin grafts was gradually obvious. Among them, the shrinkage healing of wound of nude mice in PBS group was more significant than that in ESCs group. On PSD 3, the skin graft of 1 nude mouse failed in ESCs group, while the skin graft of 3 nude mice failed in PBS group. On PSD 7, the skin graft of another nude mouse failed in PBS group. The survival ratio of skin grafts of nude mice in the two groups was similar on PSD 3, 7, 14, and 21 (P>0.05). On PSD 3, 7, 14, and 21, the shrinkage rates of skin grafts of nude mice in ESCs group were (9.2±0.4)%, (19.7±1.2)%, (53.6±3.5)%, and (62.2±5.1)%, respectively, which was significantly lower than (11.0±0.9)%, (47.8±2.8)%, (86.1±7.1)%, and (89.7±9.0)% in PBS group (t=5.719, 26.650, 11.940, 7.617, P<0.01). On PSD 3, 7, and 14, blood perfusion signals were observed in the skin grafts of nude mice in the two groups. The average blood perfusion ratios of the skin grafts of nude mice in ESCs group to PBS group were greater than 1, and there was no statistically significant difference in the overall comparison of 3 time points (P>0.05). On PSD 7, compared with those of PBS group, the mRNA and protein expressions of TNF-α, IL-8, type Ⅰ collagen, and type Ⅲ collagen in the skin graft tissue of nude mice in ESCs group were significantly reduced, while the mRNA and protein expressions of IL-10 and MMP-9 in the skin graft tissue of nude mice in ESCs group were significantly increased (in mRNA comparison, t=2.823, 2.934, 2.845, 2.860, 3.877, 2.916, P<0.05). Conclusions: Allogeneic ESCs can reduce the shrinkage of allogeneic full-thickness skin grafts transplanted on full-thickness skin defect wounds in nude mice, promote the formation of new blood vessels between the skin graft and the wound, reduce inflammation and collagen protein expression, and promote the expression of MMP-9, thus improving the survival quality of skin grafts.
Collapse
Affiliation(s)
- S B Huang
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - Z C Hu
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - Y Zhang
- Department of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China
| | - B Tang
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - P Wang
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - H L Xu
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - Z Y Wang
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - Y X Dong
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - P Cheng
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - Y C Rong
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| | - J Wu
- Department of Burns and Plastic Surgery, the First Affiliated Hospital of Shenzhen University, Shenzhen 518037, China
| | - J Y Zhu
- Department of Burns, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
| |
Collapse
|
20
|
Haake M, Schäfer T, Haack B, Vashist N, Genßler S, Harter P, Martens A, Wistuba-Hamprecht K, Wedekink F, Fischer B, Mittelbronn M, Levesque M, Cheng P, Dummer R, Weide B, Klar K, Leo E, Nimmerjahn F, Schuberth-Wagner C, Wischhusen J. 568 Tumor-derived GDF-15 prevents therapy success of checkpoint inhibitors by blocking T-lymphocyte recruitment. J Immunother Cancer 2021. [DOI: 10.1136/jitc-2021-sitc2021.568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
BackgroundImmune checkpoint blockade (ICB) can achieve durable responses in a subgroup of patients with metastatic cancer, only. Poor immune effector cell infiltration into the tumor microenvironment is a major obstacle to successful therapy. Growth and differentiation factor 15 (GDF-15) is a divergent member of the TGF-β superfamily and has been linked to feto-maternal tolerance, anorexia but recently also to potent local immunosuppression under physiologic and pathophysiologic conditions. GDF-15 is overexpressed in a wide variety of tumors and may be key factor produced by tumors to prevent effective immune cell infiltration into the tumor and to potently block checkpoint inhibitor activity.MethodsEffects of recombinant GDF-15 and a proprietary GDF-15 neutralizing antibody (CTL-002) on immune cell trafficking and activation were analyzed by adhesion and interaction assays and in melanoma-bearing humanized mouse models. The impact of GDF-15 overexpression was tested in subcutaneously implanted, GDF-15-transgenic MC38 cells. Additionally, patient GDF-15 serum levels were correlated with immune infiltration and OS in cutaneous melanoma. Associations between GDF-15 serum levels, response to PD-1-based ICB and corresponding OS were assessed in two independent cohorts of melanoma patients.ResultsGDF-15 impairs adhesion of T and NK cells on activated endothelia. In HV18-MK bearing humanized mice, inhibition of GDF-15 strongly enhances infiltration of activated myeloid and lymphoid cells. In MC38 tumors, GDF-15 overexpression can abrogate tumor rejection upon anti-PD-1 therapy. 50% of the mice with GDF-15 overexpressing tumors were, however, rescued when anti-PD-1 was combined with anti-GDF-15 (CTL-002). Likewise, anti-GDF-15 improved responses to anti-CD40 + poly(I:C) in the same tumor model. Clinically, inverse correlations of GDF-15 levels with CD8+ T cell infiltration were shown for melanoma brain metastases. In two independent melanoma patient cohorts, low baseline serum GDF-15 levels predicted clinical response to anti-PD1 treatment and superior OS. Bivariate analysis including LDH indicates that GDF-15 is an independently predictor for poor survival in anti-PD-1 treated melanoma patients.ConclusionsTumor-derived GDF-15 blocks the infiltration of immune effector cells into tumor tissues. Neutralizing GDF-15 with CTL-002 restores the ability of immune cells to extravasate blood vessels and enter the tumor microenvironment in vivo. GDF-15 thus represents a promising target for cancer immunotherapy. Antibodies against GDF-15 may support treatments with anti-PD-1 and other immunotherapeutic agents. A clinical trial combining anti-GDF-15 (CTL002) with anti-PD-1 (NCT04725474, submitted Abstract ID 15073) is ongoing.Ethics ApprovalUse of patient samples for this study had been approved by the institutional ethics committee Tübingen (ethic vote 125/2015BO2). Use of surplus sera collected in the University of Zurich Hospital (USZ) Biobank during routine blood draws from consenting metastatic melanoma patients was performed according to IRB approval (KEK.Zh- 647/800) and followed the Declaration of Helsinki on Human Rights.ConsentAll patients had given written informed consent to have clinical data recorded by the Central Malignant Melanoma Registry (CMMR) database.
Collapse
|
21
|
Li W, Cheng P, Zhang JB, Zhao LM, Ma YB, Ding K. Synergism of microorganisms and enzymes in solid-state fermentation of animal feed. A review. J Anim Feed Sci 2021. [DOI: 10.22358/jafs/133151/2021] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
22
|
Cheng P, Wang Y, Sarakha M, Mailhot G. Enhancement of the photocatalytic activity of decatungstate, W10O324−, for the oxidation of sulfasalazine/sulfapyridine in the presence of hydrogen peroxide. J Photochem Photobiol A Chem 2021. [DOI: 10.1016/j.jphotochem.2020.112890] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
23
|
Jia WX, Li WR, Wu YD, Zhang YY, Cheng P, Xiao XM, Li CR. A de novo missense mutation of the CYLD gene with multiple familial trichoepithelioma. Clin Exp Dermatol 2020; 46:792-794. [PMID: 33215749 DOI: 10.1111/ced.14515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 10/20/2020] [Accepted: 11/17/2020] [Indexed: 11/28/2022]
Affiliation(s)
- W-X Jia
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| | - W-R Li
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| | - Y-D Wu
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| | - Y-Y Zhang
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| | - P Cheng
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| | - X-M Xiao
- Department of Dermatology, The Union Hospital, Fujian Medical University, Fuzhou, China
| | - C-R Li
- Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
| |
Collapse
|
24
|
Maul JT, Maul LV, Kägi M, Cheng P, Anzengruber F, von Laue M, Chen Y, Kägi M, Navarini A. Skin Recovery After Discontinuation of Long-Term Moisturizer Application: A Split-Face Comparison Pilot Study. Dermatol Ther (Heidelb) 2020; 10:1371-1382. [PMID: 33026578 PMCID: PMC7649173 DOI: 10.1007/s13555-020-00453-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Indexed: 11/29/2022] Open
Abstract
Introduction Facial moisturizers are commonly used by healthy women and increasingly men of all age groups. This study aimed to investigate the effects of moisturizer discontinuation and the subsequent evolution of symptoms. Methods Two prospective observational split-face comparison pilot studies were performed in Switzerland and enrolled (I) 20 healthy women aged 17–25 years in winter and (II) 36 female subjects 15–20 and 40–55 years of age in summer. Moisturizers were stopped on the investigational half of the face. On the control side, the usual skin care regimen was continued. Daily subjective (I/II) and objective (I) skin assessments for the occurrence of typical symptoms of dry skin (dryness, itching, scales, redness, wrinkles) were collected. Results In the winter study (cohort I) in both the subjective and objective assessment, all skin changes increased significantly within 1 day after discontinuation. On day 7, dryness (p < 0.001), itching (p < 0.025), redness (p < 0.001) and scales (p < 0.049) were significantly different in the subjective assessment and redness (p < 0.004) and scales (p < 0.001) in the objective assessment. Skin dryness reverted to baseline levels after 6 days in the objective assessment and 10 days in the subjective assessment. The control side’s condition was reached after 6 days. In the summer study (II), only among the 15–20-year-olds was dryness significantly higher on the intervention side from day 1 (p < 0.028) to day 14 (p < 0.009). Their recovery time was 11 days until dryness intensity scores comparable to baseline were reached, and 21 days until the control side’s values were matched. Over a 7-day period, the overall mean dryness score was significantly different between the interventional and control sides for both young and old participants. Conclusions Both healthy young and aging female subjects react with typical symptoms of temporary dryness to a sudden stop of a previous long-term moisturizer treatment but regain normal levels quickly without continuation of moisturizers. The skin recovery time for skin dehydration is 1–3 weeks in young female subjects with varying intensities depending on the season. Electronic supplementary material The online version of this article (10.1007/s13555-020-00453-0) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Julia-Tatjana Maul
- Department of Dermatology, University Hospital of Zürich, Zurich, Switzerland.
| | - Lara Valeska Maul
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - Marc Kägi
- Faculty of Medicine, University of Zürich, Zurich, Switzerland.,Hautzentrum, Zürich AG, Zurich, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital of Zürich, Zurich, Switzerland
| | - Florian Anzengruber
- Department of Dermatology, University Hospital of Zürich, Zurich, Switzerland
| | | | - Yuki Chen
- Faculty of Medicine, University of Bern, Bern, Switzerland
| | - Martin Kägi
- Faculty of Medicine, University of Zürich, Zurich, Switzerland.,Hautzentrum, Zürich AG, Zurich, Switzerland
| | - Alexander Navarini
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| |
Collapse
|
25
|
Lee CK, Leung JNS, Cheng P, Lung DC, To KKW, Tsang DNC. Absence of SARS-CoV-2 viraemia in a blood donor with COVID-19 post-donation. Transfus Med 2020; 31:223-224. [PMID: 33015920 PMCID: PMC7677860 DOI: 10.1111/tme.12724] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Accepted: 09/22/2020] [Indexed: 12/01/2022]
Affiliation(s)
- C K Lee
- Hong Kong Red Cross Blood Transfusion Service, Hong Kong, SAR, China
| | - J N S Leung
- Hong Kong Red Cross Blood Transfusion Service, Hong Kong, SAR, China
| | - P Cheng
- Public Health Laboratory Centre, Centre for Health Protection, Department of Health, Hong Kong, SAR, China
| | - D C Lung
- Department of Pathology, Queen Elizabeth Hospital, Hong Kong, SAR, China
| | - K K W To
- State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
| | - D N C Tsang
- Public Health Laboratory Centre, Centre for Health Protection, Department of Health, Hong Kong, SAR, China
| |
Collapse
|
26
|
Goggi JL, Tan YX, Hartimath SV, Jieu B, Hwang YY, Jiang L, Boominathan R, Cheng P, Yuen TY, Chin HX, Tang JR, Larbi A, Chacko AM, Renia L, Johannes C, Robins EG. Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes. Mol Imaging Biol 2020; 22:1392-1402. [PMID: 32705455 PMCID: PMC7497445 DOI: 10.1007/s11307-020-01519-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PURPOSE Immune checkpoint inhibitor (ICI) monotherapy and combination regimens are being actively pursued as strategies to improve durable response rates in cancer patients. However, the biology surrounding combination therapies is not well understood and may increase the likelihood of immune-mediated adverse events. Accurate stratification of ICI response by non-invasive PET imaging may help ensure safe therapy management across a wide number of cancer phenotypes. PROCEDURES We have assessed the ability of a fluorine-labelled peptide, [18F]AlF-mNOTA-GZP, targeting granzyme B, to stratify ICI response in two syngeneic models of colon cancer, CT26 and MC38. In vivo tumour uptake of [18F]AlF-mNOTA-GZP following ICI monotherapy, or in combination with PD-1 was characterised and correlated with changes in tumour-associated immune cell populations. RESULTS [18F]AlF-mNOTA-GZP showed good predictive ability and correlated well with changes in tumour-associated T cells, especially CD8+ T cells; however, overall uptake and response to monotherapy or combination therapies was very different in the CT26 and MC38 tumours, likely due to the immunostimulatory environment imbued by the MSI-high phenotype in MC38 tumours. CONCLUSIONS [18F]AlF-mNOTA-GZP uptake correlates well with changes in CD8+ T cell populations and is able to stratify tumour response to a range of ICIs administered as monotherapies or in combination. However, tracer uptake can be significantly affected by preexisting phenotypic abnormalities potentially confusing data interpretation.
Collapse
Affiliation(s)
- J L Goggi
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - Y X Tan
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - S V Hartimath
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - B Jieu
- Institute of Chemical and Engineering Sciences (ICES), A*STAR, 8 Biomedical Grove, #07, Neuros, 138665, Singapore
| | - Y Y Hwang
- Singapore Immunology Network, A*STAR, 8A Biomedical Grove, Immunos, 138648, Singapore
| | - L Jiang
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - R Boominathan
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - P Cheng
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - T Y Yuen
- Institute of Chemical and Engineering Sciences (ICES), A*STAR, 8 Biomedical Grove, #07, Neuros, 138665, Singapore
| | - H X Chin
- Singapore Immunology Network, A*STAR, 8A Biomedical Grove, Immunos, 138648, Singapore
| | - J R Tang
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore
| | - A Larbi
- Singapore Immunology Network, A*STAR, 8A Biomedical Grove, Immunos, 138648, Singapore
| | - A M Chacko
- Laboratory for Translational and Molecular Imaging (LTMI), Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore
| | - L Renia
- Singapore Immunology Network, A*STAR, 8A Biomedical Grove, Immunos, 138648, Singapore
| | - C Johannes
- p53 Laboratory, A*STAR, 8A Biomedical Grove, #06-04/05, Neuros/Immunos, 138665, Singapore
| | - Edward G Robins
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #01-02, Helios, 138667, Singapore.
- Clinical Imaging Research Centre (CIRC), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
| |
Collapse
|
27
|
Kaufmann C, Kempf W, Mangana J, Cheng P, Emberger M, Lang R, Kaiser AK, Lattmann E, Levesque M, Dummer R, Koelblinger P. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma. Histopathology 2020; 77:460-470. [PMID: 32374893 PMCID: PMC7540531 DOI: 10.1111/his.14139] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2019] [Accepted: 05/03/2020] [Indexed: 12/16/2022]
Abstract
AIMS Despite their low individual metastatic potential, thin melanomas (≤1 mm Breslow thickness) contribute significantly to melanoma mortality overall. Therefore, identification of prognostic biomarkers is particularly important in this subgroup of melanoma. Prompted by preclinical results, we investigated cyclin D1 protein and Ki-67 expression in in-situ, metastatic and non-metastatic thin melanomas. METHODS AND RESULTS Immunohistochemistry was performed on 112 melanoma specimens, comprising 22 in situ, 48 non-metastatic and 42 metastatic thin melanomas. Overall, epidermal and dermal cyclin D1 and Ki-67 expression were semiquantitatively evaluated by three independent investigators and compared between groups. Epidermal Ki-67 expression did not differ statistically in in-situ and invasive melanoma (P = 0.7). Epidermal cyclin D1 expression was significantly higher in thin invasive than in in-situ melanoma (P = 0.003). No difference was found in cyclin D1 expression between metastatic and non-metastatic invasive tumours. Metastatic and non-metastatic thin melanomas did not show significant differences in epidermal expression of Ki-67 and cyclin D1 (P = 0.148 and P = 0.611, respectively). In contrast, strong dermal expression of Ki-67 was more frequent in metastatic than non-metastatic samples (28.6 versus 8.3%, respectively, P = 0.001). The prognostic value of dermal Ki-67 expression was confirmed by multivariate analysis (P = 0.047). CONCLUSION We found an increased expression of cyclin D1 in invasive thin melanomas compared to in-situ melanomas, which supports a potential role of this protein in early invasion in melanoma, as suggested by preclinical findings. Moreover, our results confirm that high dermal Ki-67 expression is associated with an increased risk of development of metastasis in thin melanoma and could possibly serve as a prognostic biomarker in clinical practice, especially if combined with additional methods.
Collapse
Affiliation(s)
- Corina Kaufmann
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
- University of ZurichZurichSwitzerland
| | - Werner Kempf
- Kempf and Pfaltz Histological DiagnosticsZurichSwitzerland
| | - Joanna Mangana
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
| | - Phil Cheng
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
| | | | - Roland Lang
- Department of Dermatology and AllergologyParacelsus Medical UniversitySalzburgAustria
| | - Andreas K Kaiser
- Department of Clinical PsychologyChristian‐Doppler‐KlinikParacelsus Medical UniversitySalzburgAustria
| | | | - Mitchell Levesque
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
| | - Reinhard Dummer
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
| | - Peter Koelblinger
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
- Department of Dermatology and AllergologyParacelsus Medical UniversitySalzburgAustria
| |
Collapse
|
28
|
Wischhusen J, Wistuba-Hamprecht K, Harter PN, Cheng P, Martens A, Gogolla F, Nonomura Y, Romer P, Koch SD, Haake M, Schuberth-Wagner C, Rudiger M, Leo E, Mittelbronn M, Levesque MP, Hackl H, Dummer R, Weide B. Abstract 2161: Identifying GDF-15 as potential novel immunotherapeutic target linked to immune cell exclusion in tumors and resistance to anti-PD-1 treatment. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-2161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction:
Growth and differentiation factor 15 (GDF-15) is a TGF-β superfamily member mainly expressed in placenta and prostate of healthy individuals. GDF-15 has been linked to feto-maternal tolerance, prevention of excessive immune cell infiltration during tissue damage and to anorexia. In cancer patients, GDF-15 serum levels are frequently elevated and associated with poor prognosis, via so far mostly unknown mechanism(s). A recent study elucidated a mechanism by which GDF-15 inhibits LFA-1 activation on CD8+ T cells, thus interfering with T cell recruitment to tissues [Haake et al. AACR 2020; submitted]. To further delineate the role of GDF-15 in cancer in this study GDF-15 serum and tissue levels were analyzed and correlated with tumoral immune-cell infiltration and clinical anti-PD1 response.
Methods:
In-silico, TCGA-derived mRNA levels of GDF-15 were compared in cancer vs. normal tissue. Two independent melanoma patient cohorts (88 and 34 patients) treated with nivolumab or pembrolizumab were analyzed regarding baseline GDF-15 serum levels, correlation with clinical response and overall survival. Melanoma brain metastases from 80 patients were collected to assess and compare intratumoral GDF-15 levels vs. CD3+, CD8+ and Foxp3+ cell numbers by immunohistochemistry (IHC).
Results:
TCGA-based analyses demonstrated significantly elevated GDF-15 mRNA levels in tumor vs. surrounding normal tissue in various major cancer types such as e.g. colorectal, prostate, head & neck and melanoma. In the two independent, anti-PD1 treated melanoma patient cohorts baseline serum GDF-15 levels were predictive for superior overall survival and clinical response to anti-PD1 treatment (p<0.0001 and p=0.0382, respectively). In melanoma biopsies an inverse correlation of GDF-15 levels (histoscore) with CD3+ (R=-0.26; p=0.016) and CD8+ T cells (R=-0.21; p=0.05), but no correlation with Foxp3+ T cells was shown.
Conclusion:
GDF-15 is elevated in serum and tumor tissue of various major cancer types. In melanoma, patients with higher GDF-15 levels have significantly shorter survival and are less likely to respond to anti-PD1 therapy. In addition, intratumoral GDF-15 levels in melanoma brain metastasis correlate inversely with CD3+ and CD8+ T cell infiltration. Consequently, GDF-15 may serve as a predictive biomarker for anti-PD1 response and potentially represent a novel target in the immunotherapy of cancer to improve tumor immune cell infiltration and anti-PD1 response.
Citation Format: Jorg Wischhusen, Kilian Wistuba-Hamprecht, Patrick N. Harter, Phil Cheng, Alexander Martens, Falk Gogolla, Yumi Nonomura, Paula Romer, Sven D. Koch, Markus Haake, Christine Schuberth-Wagner, Manfred Rudiger, Eugen Leo, Michael Mittelbronn, Mitchell P. Levesque, Hubert Hackl, Reinhard Dummer, Benjamin Weide. Identifying GDF-15 as potential novel immunotherapeutic target linked to immune cell exclusion in tumors and resistance to anti-PD-1 treatment [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2161.
Collapse
Affiliation(s)
- Jorg Wischhusen
- 1University of Wurzburg, Clinics for Gynecology and Obstetrics, Center for Clinical Research, Catalym GmbH, Planegg-Martinsried, Germany; Catalym GmbH, Planegg-Martinsried, Germany, Wurzburg, Germany
| | | | - Patrick N. Harter
- 3German Cancer Research Center (DKFZ), Heidelberg, Germany; Neurological Institute (Edinger Institute) University Hospital Franfurt; Frankfurt Cancer Institute (FCI); German Cancer Konsortium (DKTK), Frankfurt, Germany
| | - Phil Cheng
- 4University of Zurich, University of Zurich Hospital, Zurich, Switzerland
| | - Alexander Martens
- 2University of Tubingen, University Medical Center, Tubingen, Germany
| | - Falk Gogolla
- 5Medical University of Innsbruck, Institute of Bioinformatics, Innsbruck, Austria
| | - Yumi Nonomura
- 4University of Zurich, University of Zurich Hospital, Zurich, Switzerland
| | - Paula Romer
- 6University of Wurzburg, Clinics for Gynecology and Obstetrics, Center for Clinical Research; Catalym GmbH, Planegg-Martinsried, Germany, Wurzburg, Germany
| | | | | | | | | | - Eugen Leo
- 7CatalYm GmbH, Planegg-Martinsried, Germany
| | - Michael Mittelbronn
- 8National Center of Pathology (NCP), Dudelange Luxembourg; Luxembourg Center of Neuropathology (LCNP); Luxembourg Institute of Health (LIH); Luxembourg Centre of Systems Biomedicine (LCSB), Esch-sur-Alzette, Luxembourg
| | | | - Hubert Hackl
- 5Medical University of Innsbruck, Institute of Bioinformatics, Innsbruck, Austria
| | - Reinhard Dummer
- 4University of Zurich, University of Zurich Hospital, Zurich, Switzerland
| | - Benjamin Weide
- 2University of Tubingen, University Medical Center, Tubingen, Germany
| |
Collapse
|
29
|
Mann E, Sagong C, Cuamatzi Castelan A, Singh M, Roth T, Drake CL, Cheng P. 0007 Daytime Sleep in Night Shift Workers: Quantifying the Role of Circadian Misalignment. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Circadian misalignment is commonly cited as a culprit of daytime sleep disturbances in night shift workers; however, the specific impact and magnitude that circadian misalignment has on daytime sleep has not been well-characterized in larger samples of night shift workers.
Methods
Participants included fixed-night shift workers (n=52, ages 18–50) who completed an 8-hour daytime polysomnography (PSG) in the lab following a night shift. Measures of sleep disturbances included: difficulty falling asleep (sleep onset latency [SOL], latency to persistent sleep [LPS]), difficulty staying asleep (sleep efficiency [SE], wake after sleep onset [WASO]), and sleep duration (total sleep time [TST]). Melatonin samples were collected hourly for 24 hours under dim light (<10 lux) and used to determine dim light melatonin offset (DLMOff). Circadian misalignment (CM) was calculated as the time difference between bedtime and DLMOff (higher values represented sleeping after DLMOff), and correlated with PSG sleep variables.
Results
CM was significantly associated with difficulty staying asleep (WASO: r=0.48, p<0.001; SE: r=-0.45, p<0.001), and sleep duration (TST: r=-0.38, p<0.01). Specifically, every 3 hours of CM on average added 19.2 minutes of WASO and reduced TST by 15 minutes. In contrast, CM was not significantly correlated with sleep onset difficulties (SOL: r=-0.27; LPS: r=-0.02).
Conclusion
These data suggest that circadian misalignment in shift workers may be a better predictor of difficulties staying asleep and sleep duration during the day relative to difficulties falling asleep. Because longer work hours (10–12 hours) are common in night shift worker, it may be that sleep initiation difficulties associated with circadian misalignment is masked by elevated fatigue or an increased homeostatic drive from prolonged wakefulness. These results may help guide decisions about the magnitude of phase shifts required (e.g., with light therapy) for the desired improvement in daytime sleep.
Support
Support for this study was provided to PC by the NHLBI (K23HL138166)
Collapse
Affiliation(s)
- E Mann
- Henry Ford Health System, Detroit, MI
| | - C Sagong
- Henry Ford Health System, Detroit, MI
| | | | - M Singh
- Henry Ford Health System, Detroit, MI
| | - T Roth
- Henry Ford Health System, Detroit, MI
| | - C L Drake
- Henry Ford Health System, Detroit, MI
| | - P Cheng
- Henry Ford Health System, Detroit, MI
| |
Collapse
|
30
|
Schaap E, Sagong C, Cuamatzi Castelan AS, Sayed J, Roth T, Drake CL, Cheng P. 0006 The Role of Stress in Sleep in Night Shift Workers: Going Beyond Circadian Misalignment. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Despite a growing need for nighttime work, few studies have characterized the causes of sleep disturbance in night shift workers beyond circadian misalignment. Recent research suggest that high sleep reactivity to stress (a predisposition for sleep disturbance due to stress) may also lead to sleep difficulties in shift workers. This study investigated if sleep reactivity is an independent predictor of daytime sleep disturbances after controlling for circadian phase.
Methods
Night shift workers (N= 48) completed an 8 hour polysomnography (PSG) during the daytime following a night shift (9am - 4pm). Circadian phase was measured using melatonin assays of saliva samples collected over 24 hours under dim light (<10 lux; Dim Light Melatonin Onset [DLMO]). Sleep reactivity was measured using the Ford Insomnia Response to Stress Test (FIRST). Linear regressions were conducted with PSG sleep parameters as outcome variables: difficulty falling asleep (Sleep Onset Latency [SOL] and Latency to Persistent Sleep [LPS]), difficulty staying asleep (Wake After Sleep Onset [WASO]), and sleep duration (Total Sleep Time [TST]). FIRST was tested as a predictor controlling for DLMO.
Results
After controlling for circadian phase, higher FIRST scores was associated with more difficulty staying asleep (WASO: t[45]=4.059, p<0.001) and shorter sleep duration (TST: t[45] = -4.403, p<0.0001), but not predictive of difficulty falling asleep (SOL: p>0.05). However, higher FIRST scores did predict a longer latency to persistent sleep (LPS: t[45]=2.272, p<0.05).
Conclusion
These results suggest that sleep reactivity to stress and circadian misalignment are independent processes that are both associated with disrupted daytime sleep in night shift workers. Given that night shift work can also cause psychosocial stress, treatments focused on circadian misalignment alone may not be sufficient. Our study highlights the need to consider sleep reactivity in the clinical management of shift work disorder.
Support
Support for this study was provided to PC by NHLBI (K23HL138166).
Collapse
Affiliation(s)
- E Schaap
- Henry Ford Health System, Detroit, MI
| | - C Sagong
- Henry Ford Health System, Detroit, MI
| | | | - J Sayed
- Henry Ford Health System, Detroit, MI
| | - T Roth
- Henry Ford Health System, Detroit, MI
| | - C L Drake
- Henry Ford Health System, Detroit, MI
| | - P Cheng
- Henry Ford Health System, Detroit, MI
| |
Collapse
|
31
|
Murugan N, Sagong C, Cuamatzi Castelan AS, Moss K, Roth T, Drake CL, Cheng P. 0203 To and From the Night Shift: Risky On-the-Road Driving in Night Shift Workers. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Drowsy driving is a common occupational hazard for night shift workers (NSWs). While sleep loss is commonly identified as the primary culprit of drowsy driving, another critical factor to consider is circadian phase. However, the role of circadian phase in driving safety has not been well characterized in NSWs. This study examined if dim light melatonin offset (DLMOff, i.e. the cessation of melatonin secretion) is also a relevant phase marker of susceptibility to four different subtypes of risky on-the-road driving behaviors.
Methods
On-the-road driving was monitored over 8 weeks via a mobile application that tracked risky driving behaviors using accelerometer and GPS data from cell phones (N=15; 3052 total driving events recorded). Risky driving behaviors included: 1) frequency of hard-braking events, 2) frequency of aggressive-acceleration events, 3) duration of excessive-speeding, and 4) duration of phone-usage. At week 2, participants spent 24 hours in-lab where hourly saliva samples were collected and assayed for melatonin, and DLMOff was calculated. Phase angle of driving events relative to DLMOff was used as the predictor in nested mixed-effects regressions, with risky driving behaviors as the outcome variables.
Results
The most common occurrences of risky driving were phone-usage and hard-braking. On average, NSWs had 46.7% and 42.0% of driving events with at least one occurrence of phone-usage and hard-braking, respectively. Rates of aggressive-acceleration and speeding were 24.4% and 20.4%. Positive phase angles (i.e. driving after DLMOff) were associated with reduced rates of hard-braking and aggressive-acceleration, but not of phone-usage and excessive-speeding. Specifically, rates of hard-braking and aggressive-acceleration decreased by 4.5% (p<.01) and 3.4% (p=.05) every two hours following DLMOff, respectively.
Conclusion
The study suggests DLMOff appears to be an important variable for predicting accident risk in NSWs. If replicated, circadian phase should be considered in recommendations to increase occupational health and safety of NSWs.
Support
Support for this study was provided to PC by NHLBI (K23HL138166).
Collapse
Affiliation(s)
- N Murugan
- Henry Ford Health System, Detroit, MI
| | - C Sagong
- Henry Ford Health System, Detroit, MI
| | | | - K Moss
- Henry Ford Health System, Detroit, MI
| | - T Roth
- Henry Ford Health System, Detroit, MI
| | - C L Drake
- Henry Ford Health System, Detroit, MI
| | - P Cheng
- Henry Ford Health System, Detroit, MI
| |
Collapse
|
32
|
Drake CL, Cheng P, Kalmbach D, Roth T, Sagong C, Arnett L. 0465 Association Between Physical or Sexual Abuse and Sleep Reactivity in Patients with Insomnia. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Physical and sexual abuse are common and have demonstrated associations with insomnia. A common factor predisposing individuals to the development of insomnia is sleep reactivity, yet no studies have determined the relationship between sleep reactivity and physical and/or sexual abuse.
Methods
Patients with DSM-5 insomnia disorder (N = 658; 519 F; mean age = 45.03) participated in an online randomized controlled trial of behavioral treatment of insomnia. Participants completed the Insomnia Severity Index (ISI), Ford Insomnia Response to Stress Test (FIRST), and demographic information at baseline. Abuse history was assessed with a single 4-choice item asking participants if they had a history of physical or sexual abuse. One-way analysis of variance was used to determine the level of sleep reactivity in each of the 4 abuse groups (none, physical, sexual, both) controlling for insomnia (ISI). Post-hoc analyses also compared differences in self-reported difficulties falling and staying asleep.
Results
Compared to those with no abuse history (n = 465), patients who reported both physical and sexual abuse (n = 50) had significantly elevated FIRST scores (p < .001). Results remained significant after controlling for severity of insomnia, age, and gender. Post-hoc analyses showed group differences in sleep onset latency but not wake after sleep onset.
Conclusion
Combined physical and sexual abuse are associated with higher levels of sleep reactivity to stress, and that the effects may be most prominent for difficulties falling asleep and not sleep maintenance. Prospective studies are needed to determine the potential effects of abuse on sleep reactivity, and whether sensitization of the sleep system to stress constitutes an etiological pathway in the development of insomnia disorder in survivors of abuse. Future work should also investigate potential overlapping biological markers of abuse and sleep reactivity.
Support
This study was funded by the Robert Wood Johnson Foundation (PI: Drake).
Collapse
Affiliation(s)
- C L Drake
- Henry Ford Health System, Detroit, MI
| | - P Cheng
- Henry Ford Health System, Detroit, MI
| | | | - T Roth
- Henry Ford Health System, Detroit, MI
| | - C Sagong
- Henry Ford Health System, Detoirt, MI
| | - L Arnett
- Henry Ford Health System, Detoirt, MI
| |
Collapse
|
33
|
Van Name MA, Cheng P, Gal RL, Kollman C, Lynch J, Nelson B, Tamborlane WV. Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control. Diabet Med 2020; 37:863-867. [PMID: 31943374 DOI: 10.1111/dme.14233] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/09/2020] [Indexed: 01/10/2023]
Abstract
AIM To compare the characteristics of children and adolescents with type 1 vs. type 2 diabetes in the Pediatric Diabetes Consortium (PDC) registries. METHODS Participants were 10 to < 21 years of age at diagnosis; there were 484 with type 1 diabetes and 1236 with type 2 diabetes. RESULTS Children and adolescents with type 2 diabetes were more likely to be female, overweight/obese, and from low-income, minority ethnic families. Children and adolescents with type 1 diabetes were more likely to present with diabetic ketoacidosis and have higher mean HbA1c levels at diagnosis. More than 70% in both cohorts achieved target HbA1c levels < 58 mmol/mol (< 7.5%) within 6 months, but fewer participants with type 1 than type 2 diabetes were able to maintain target HbA1c levels after 6 months consistently throughout 3 years post diagnosis. Of the 401 participants with type 2 diabetes with ≥ 24 months diabetes duration on enrolment in the registry, 47% required no insulin treatment. Median C-peptide levels were 1.43 mmol/l in the subset of participants with type 2 diabetes in whom it was measured, but only 0.06 mmol/l in the subset with type 1 diabetes. CONCLUSIONS Although families of children and adolescents with type 2 diabetes face greater socio-economic obstacles and risk factors for poor diabetes outcomes, the greater retention of residual endogenous insulin secretion likely contributes to the increased ability of children and adolescents with type 2 diabetes to maintain target HbA1c during the first 3 years of diabetes diagnosis.
Collapse
Affiliation(s)
- M A Van Name
- Pediatric Endocrinology, Yale University, New Haven, CT, USA
| | - P Cheng
- Jaeb Center for Health Research, Tampa, FL, USA
| | - R L Gal
- Jaeb Center for Health Research, Tampa, FL, USA
| | - C Kollman
- Jaeb Center for Health Research, Tampa, FL, USA
| | - J Lynch
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | - B Nelson
- School of Medicine-Greenville, University of South Carolina, Greenville, SC, USA
| | - W V Tamborlane
- Pediatric Endocrinology, Yale University, New Haven, CT, USA
| |
Collapse
|
34
|
Huang T, Zhu L, Zhang SF, Hu XY, Cheng P, Luan SQ, Chen GH. A rare case of ring chromosome 3 syndrome. J BIOL REG HOMEOS AG 2020; 34:13. [PMID: 32090537 DOI: 10.23812/19-277-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- T Huang
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - L Zhu
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - S F Zhang
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - X Y Hu
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - P Cheng
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - S Q Luan
- Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - G H Chen
- Department of Pediatrics, The First Affiliated Hospital of Nanchang University, Nanchang, China
| |
Collapse
|
35
|
Keihani S, Wright L, Alder N, Cheng P, Stoddard G, Pastuszak A, Deibert C. 372 Baseline Gonadotropin Levels do not Predict Testosterone Response in Hypogonadal Men Treated with Clomiphene Citrate. J Sex Med 2020. [DOI: 10.1016/j.jsxm.2019.11.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Hartwig T, Zwicky P, Schreiner B, Yawalkar N, Cheng P, Navarini A, Dummer R, Flatz L, Conrad C, Schlapbach C, Becher B. Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell Rep 2019; 25:3564-3572.e4. [PMID: 30590032 DOI: 10.1016/j.celrep.2018.12.012] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2018] [Revised: 11/13/2018] [Accepted: 12/03/2018] [Indexed: 12/17/2022] Open
Abstract
Psoriasis is a chronic relapsing, remitting interleukin (IL)-23/IL-17-driven skin disease mediated by the interplay of T cells and polymorphonuclear granulocytes. Although preclinical studies have provided insights into the mechanisms of disease initiation, the underpinnings of natural disease remission remain largely unknown. Here, we addressed the contribution of regulatory Foxp3+ T cells (Treg cells) in psoriasiform skin inflammation and remission using the Aldara-skin inflammation model in combination with the inducible depletion of Foxp3+ Treg cells. Loss of Treg cells exacerbated skin inflammation, but this did not involve increased γδ T cell expansion or the local production of the psoriasis-associated cytokines IL-17A, IL-17F, and IL-22, which are the main driving forces of disease development. Instead, Treg cells suppressed the infiltration of granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing CD4+ T cells into the lesioned skin, and neutralizing GM-CSF in Treg cell-deficient mice reversed hyper-inflammation, resulting in disease regression. Therefore, we identified a non-redundant role of Treg cells restraining skin inflammation and mediating skin homeostasis.
Collapse
Affiliation(s)
- Tom Hartwig
- Institute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland
| | - Pascale Zwicky
- Institute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland
| | - Bettina Schreiner
- Institute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland; Department of Neurology, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Nikhil Yawalkar
- Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Alexander Navarini
- Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Reinhard Dummer
- Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Lukas Flatz
- Department of Dermatology and Allergology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
| | - Curdin Conrad
- Department of Dermatology, University Hospital CHUV, Lausanne 1011, Switzerland
| | - Christoph Schlapbach
- Department of Dermatology, Inselspital, University of Bern, 3010 Bern, Switzerland
| | - Burkhard Becher
- Institute of Experimental Immunology, Department of Inflammation Research, University of Zurich, 8057 Zurich, Switzerland.
| |
Collapse
|
37
|
Zhang BG, Li YP, Ma R, Cheng P, Guo XX, Wang HF, Liu LJ. [Effects of low temperature on trehalose and trehalase contents in Culex pipiens pallens]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2019; 31:510-512. [PMID: 31713380 DOI: 10.16250/j.32.1374.2018131] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To examine the effect of low temperature on trehalose and trehalase levels in Culex pipiens pallens. METHODS The fourth instar larvae and female adult mosquitoes of Cx. pipiens pallens were exposed at 4 ℃ for 0, 1, 3, 6, 12, 18, 24 h and 0, 1, 3, 6, 12, 18, 24, 36, 48, 72 h, respectively. Then, the trehalose and trehalase contents were detected by enzyme-linked immunosorbent assay (ELISA) in mosquitoes. RESULTS The contents of trehalose and trehalase significantly increased in the larval and female adult mosquitoes post-exposure to low temperature. The changing trend of trehalose levels was consistent in the larval and female adult mosquitoes, and the highest levels were (2.458 8 ± 0.379 2) mg/g and (2.825 7 ± 0.211 1) mg/g 3 h post-exposure to low temperature, respectively. The trehalose and trehalase levels fluctuated greatly within the first 6 h post-exposure to low temperature. Following adaptation for a period of time, the trehalose and trehalase levels remained at a relatively high level. CONCLUSIONS Low temperature may induce the production of trehalose and trehalase in Cx. pipiens pallens, and the trehalose and trehalase may play an important role in the improvement of the cold resistance.
Collapse
Affiliation(s)
- B G Zhang
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
| | - Y P Li
- Jinxiang County Bureau of Agriculture, Shandong Province, China
| | - R Ma
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
- Jining No. 1 People's Hospital, Shandong Province, China
| | - P Cheng
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
| | - X X Guo
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
| | - H F Wang
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
| | - L J Liu
- Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining 272033, China
| |
Collapse
|
38
|
Cheng P, Lu P, Guan J, Zhou Y, Zou L, Yi X, Cheng H. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia. Neoplasma 2019; 67:238-248. [PMID: 31390869 DOI: 10.4149/neo_2018_181215n972] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2018] [Accepted: 06/11/2019] [Indexed: 11/08/2022]
Abstract
Long noncoding RNAs (lncRNAs) have been reported to play essential roles in development and treatment of acute myeloid leukemia (AML). However, the role of lncRNA potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 (KCNQ1OT1) in AML progression and its mechanism remain largely unknown. The expressions of KCNQ1OT1, microRNA-326 (miR-326) and c-Myc were measured by quantitative real-time polymerase chain reaction and western blot, respectively. Phorbol myristate acetate (PMA) was used for cell differentiation. Cell proliferation, apoptosis and differentiation were measured by MTT assay, flow cytometry and qRT-PCR, respectively. The interaction between miR-326 and KCNQ1OT1 or c-Myc was explored by luciferase activity, RNA immunoprecipitation or RNA pull-down assay. We found that the expression of KCNQ1OT1 was enhanced in AML samples compared with control. KCNQ1OT1 knockdown inhibited cell proliferation but promoted apoptosis and cell differentiation. KCNQ1OT1 was a decoy of miR-326 and c-Myc was a target of miR-326. KCNQ1OT1 regulated AML cell proliferation, apoptosis and differentiation by sponging miR-326. Moreover, overexpression of miR-326 suppressed proliferation but promoted apoptosis and PMA-induced differentiation by targeting c-Myc in AML cells. Besides, c-Myc protein level was suppressed by KCNQ1OT1 interference and rescued by miR-326 abrogation. Our data showed that KCNQ1OT1 regulates proliferation, differentiation and apoptosis in AML cells by acting as a competing endogenous RNA (ceRNA) for miR-326 to regulate c-Myc, providing a novel avenue for AML treatment.
Collapse
Affiliation(s)
- P Cheng
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| | - P Lu
- Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Guan
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| | - Y Zhou
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| | - L Zou
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| | - X Yi
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| | - H Cheng
- Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China
| |
Collapse
|
39
|
Song X, Cheng P, Wang HF, Guo XX, Lü YY, Liu HM, Liu LJ, Zhang CX, Zhao YQ, Kou JX, Wang HW, Gong MQ. [Study on insecticide resistance of Culex pipiens pallens in southwest region of Shandong Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2019; 32:69-72. [PMID: 32185930 DOI: 10.16250/j.32.1374.2018261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To explore the sensitivity of Culex pipiens pallens to common chemical insecticides in the southwestern region of Shandong Province, so as to provide a theoretical basis for the development of reasonable and effective mosquito control measures. METHODS The resistance of Cx. pipiens pallens larvae to 5 chemical insecticides, such as cypermethrin, deltamethrin, DDVP, propoxur, and acetofenate were tested by using the WHO biological test method in 2018, and the co-toxicity coefficients after compounding the above-mentioned insecticides were tested by using a drug compounding method. RESULTS The resistance indexes of Cx. pipiens pallens to cypermethrin, deltamethrin, DDVP, propoxur, and acetofenate in 3 cities were 144.43-557.54, 118.17-445.33, 6.44-19.00, 2.37-8.10, and 0.88-2.98, respectively, and expect the difference between the DDVP resistances of Cx. pipiens pallens in Jining City and Heze City was not statistically significant (P > 0.05), all the other differences were statistically significant (all P < 0.05). The synergistic coefficients of cypermethrin + DDVP, cypermethrin + propoxur, DDVP + acetofenate, and propoxur + acetofenate were 199.58 - 456.95, 190.56 - 292.37, 123.32 - 319.24, and 192.31 - 367.32, respectively. The lower synergism was observed by using the mixture of DDVP + propoxur (synergistic coefficient: 99.87-108.36) . CONCLUSIONS After decades of chemical control, Cx. pipiens pallens in the southwestern region of Shandong Province has produced different degrees of resistance to common chemical insecticides. Therefore, comprehensive control measures should be taken to control mosquito breeding and prevent the development of insecticide resistance.
Collapse
Affiliation(s)
- X Song
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
- School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, China
| | - P Cheng
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - H F Wang
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - X X Guo
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - Y Y Lü
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - H M Liu
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - L J Liu
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - C X Zhang
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - Y Q Zhao
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - J X Kou
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - H W Wang
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| | - M Q Gong
- Shandong Academy of Medical Sciences, Shandong Institute of Parasitic Diseases, Jining 272033, China
| |
Collapse
|
40
|
Liu WX, Dong M, Zhang RQ, Ma ZH, Yang QF, Chen YJ, Ye YQ, Liao LM, Cheng P, Jiang ZY, Zhou M. New Benzylated Alkamide from the Roots of Lepidium meyenii. Chem Nat Compd 2019. [DOI: 10.1007/s10600-019-02781-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
41
|
Hartimath SV, Khanapur S, Boominathan R, Jiang L, Cheng P, Yong FF, Tan PW, Robins EG, Goggi JL. Imaging adipose tissue browning using the TSPO-18kDa tracer [ 18F]FEPPA. Mol Metab 2019; 25:154-158. [PMID: 31105057 PMCID: PMC6601022 DOI: 10.1016/j.molmet.2019.05.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Revised: 04/26/2019] [Accepted: 05/02/2019] [Indexed: 12/26/2022] Open
Abstract
Objectives The browning of white adipose tissue (WAT) into beige has been proposed as a strategy to enhance energy expenditure to combat the growing epidemic of obesity. Research into browning strategies are hampered by the lack of sensitive, translatable, imaging tools capable of detecting beige fat mass non-invasively. [18F]FDG is able to detect activated beige fat but provides little information on unstimulated beige fat mass. We have assessed the use of [18F]FEPPA, a tracer for the TSPO-18KDa found on the outer mitochondrial membrane, as an alternative imaging agent capable of detecting unstimulated brown fat (BAT) and beige fat. Methods Female Balb/c mice (n = 5) were treated for 7 days with the β3 adrenergic agonist CL-316,243 to induce the browning of inguinal WAT (beige fat). Animals were imaged longitudinally with [18F]FDG and [18F]FEPPA and uptake in interscapular BAT and inguinal WAT assessed. The browning of inguinal WAT was confirmed using H&E and immunohistochemical detection of UCP-1 and TSPO. Results Repeated dosing with β3-adrenergic agonist CL-316,243 caused a significant increase in [18F]FDG uptake in both interscapular BAT and inguinal WAT associated with the increased metabolic activity of brown and beige adipocytes respectively. [18F]FEPPA uptake was likewise increased in inguinal WAT but showed no increase in BAT uptake due to stimulation over the same time course. Furthermore, inguinal WAT uptake was unaffected by pharmacological blockade, indicating that [18F]FEPPA uptake is associated with the expression of mitochondria in BAT and beige adipocytes and independent of activation. Conclusion These data show that [18F]FEPPA can detect BAT and newly formed beige fat under non-stimulated, thermoneutral conditions and that uptake after stimulation is linked to mitochondrial expression as opposed to activation. TSPO-18kDa tracers can detect BAT under non-stimulated, thermoneutral conditions. TSPO-18kDa tracers can detect the formation of beige adipocytes in white adipose tissue. TSPO-18kDa tracers may aid in the development of new approaches to treat obesity.
Collapse
Affiliation(s)
- S V Hartimath
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - S Khanapur
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - R Boominathan
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - L Jiang
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - P Cheng
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - F F Yong
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - P W Tan
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore
| | - E G Robins
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore; Clinical Imaging Research Centre, Yong Loo Lin School of Medicine, National University of Singapore, 117599, Singapore
| | - J L Goggi
- Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A* STAR), 11 Biopolis Way, #07-10, Helios, 138667, Singapore.
| |
Collapse
|
42
|
Tuncer E, Calçada RR, Zingg D, Varum S, Cheng P, Freiberger SN, Deng CX, Kleiter I, Levesque MP, Dummer R, Sommer L. SMAD signaling promotes melanoma metastasis independently of phenotype switching. J Clin Invest 2019; 129:2702-2716. [PMID: 31039140 DOI: 10.1172/jci94295] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
The development of metastatic melanoma is thought to require the dynamic shifting of neoplastic cells between proliferative and invasive phenotypes. Contrary to this conventional "phenotype switching" model, we now show that disease progression can involve malignant melanoma cells simultaneously displaying proliferative and invasive properties. Using a genetic mouse model of melanoma in combination with in vitro analyses of melanoma cell lines, we found that conditional deletion of the downstream signaling molecule Smad4, which abrogates all canonical TGF-β signaling, indeed inhibits both tumor growth and metastasis. Conditional deletion of the inhibitory signaling factor Smad7, however, generated cells that are both highly invasive and proliferative, indicating that invasiveness is compatible with a high proliferation rate. In fact, conditional Smad7 deletion led to sustained melanoma growth and at the same time promoted massive metastasis formation, a result consistent with data indicating that low SMAD7 levels in patient tumors are associated with a poor survival. Our findings reveal that modulation of SMAD7 levels can overcome the need for phenotype switching during tumor progression and may thus represent a novel therapeutic target in metastatic disease.
Collapse
Affiliation(s)
- Eylul Tuncer
- Stem Cell Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
| | - Raquel R Calçada
- Stem Cell Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
| | - Daniel Zingg
- Stem Cell Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
| | - Sandra Varum
- Stem Cell Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
| | - Phil Cheng
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
| | | | - Chu-Xia Deng
- Faculty of Health Sciences, University of Macau, Macau SAR, China
| | - Ingo Kleiter
- Department of Neurology, Ruhr-University Bochum, Bochum, Germany and Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gGmbH, Berg, Germany
| | | | - Reinhard Dummer
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
| | - Lukas Sommer
- Stem Cell Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
| |
Collapse
|
43
|
Alexander K, Barrett C, Dobos K, Cheng P, Liao R, Wheeler M, Liedtke M, Weisshaar D, Witteles R. Contemporary Outcomes in Patients with Cardiac Amyloidosis Undergoing Heart Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
44
|
Yang Y, Yuan L, Li J, Muhammad I, Cheng P, Xiao T, Zhang X. Preparation and evaluation of tilmicosin microspheres and lung-targeting studies in rabbits. Vet J 2019; 246:27-34. [PMID: 30902186 DOI: 10.1016/j.tvjl.2019.01.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2018] [Revised: 01/23/2019] [Accepted: 01/23/2019] [Indexed: 11/15/2022]
Abstract
Tilmicosin (TMS) is a macrolide used extensively for pulmonary infections in clinical veterinary medicine. However, TMS has frequent administration and short elimination half-life. Therefore, tilmicosin-gelatine microspheres (TMS-GMS) were prepared by an emulsion-chemical cross-linking technique as a sustained-release formulation to extend drug half-life. The particle size distribution, in-vitro sustained-release properties, stability, and physical characteristics, as well as pharmacokinetic (PK) characteristics, were evaluated in rabbits. TMS-GMS were spherical in shape and had a mean diameter of 11.34±1.20μm; 95.65% of the microspheres varied in size from 5.0 to 25.0μm. Light and thermal stability tests indicated no significant changes in all observed indices. Importantly, compared to crude TMS, slower release of TMS from TMS-GMS was noted in drug release studies (in vitro). Pharmacokinetic (PK) characteristics were examined in the lung, liver, heart, kidney and muscle tissue of rabbits following IM injection of TMS-GMS or TMS-injection at a dose of 10mg/kg. The elimination half-life of TMS-GMS (59.21±0.21h) was longer than that of TMS-injection (38.56±0.13h) in the lung. The ratio of peak concentration (Ce) of TMS-GMS to TMS-injection was 2.19 (>1) in the lung, demonstrating the selectivity of TMS-GMS to target the lung compared to that of other tissues (Ce<1). Interestingly, the uptake value of TMS from TMS-GMS was 8.48 times higher in the lung than that for the TMS-injection, and was slightly higher than in the liver (1.85), heart (1.72), kidney (2.44) and muscle (2.79) tissues. TMS-GMS is a sustained-release formulation of TMS with potential to be used in veterinary clinical applications; possible benefits include lung-targeting and prolonged elimination half-life.
Collapse
Affiliation(s)
- Y Yang
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China
| | - L Yuan
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China; College of Veterinary Medicine, National Reference Laboratory of Veterinary Drug Residues (SCAU), South China Agricultural University, 510642 Guangzhou, China
| | - J Li
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China
| | - I Muhammad
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China
| | - P Cheng
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China
| | - T Xiao
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China
| | - X Zhang
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Faculty of Basic Veterinary Science, College of Veterinary Medicine, Northeast Agricultural University,600 Changjiang Road, Xiangfang District, Harbin, PR China.
| |
Collapse
|
45
|
Mellett M, Meier B, Mohanan D, Schairer R, Cheng P, Satoh TK, Kiefer B, Ospelt C, Nobbe S, Thome M, Contassot E, French LE. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo. J Invest Dermatol 2018; 138:2010-2023. [DOI: 10.1016/j.jid.2018.03.1525] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Revised: 03/22/2018] [Accepted: 03/27/2018] [Indexed: 10/17/2022]
|
46
|
Mellett M, Meier B, Mohanan D, Schairer R, Cheng P, Satoh T, Kiefer B, Nobbe S, Thome M, Contassot E, French L. 993 CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.1005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Tonnu CV, Cheng P, Kalmbach D, Fellman-Couture C, Tallent G, Arnedt J, Singh M, Drake C. 0706 Impact of Behavioral Insomnia Treatment on Post-Menopausal Female Sexual Functioning. Sleep 2018. [DOI: 10.1093/sleep/zsy061.705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - P Cheng
- Henry Ford Health System, Novi, MI
| | | | | | | | - J Arnedt
- University of Michigan, Ann Arbor, MI
| | - M Singh
- Henry Ford Health System, Novi, MI
| | - C Drake
- Henry Ford Health System, Novi, MI
| |
Collapse
|
48
|
Tallent G, Cheng P, Fellman-Couture C, Tonnu C, Moss K, Arnedt T, Drake C. 0397 Impact of Behavioral Insomnia Treatments on Quality of Life in Post-Menopausal Women. Sleep 2018. [DOI: 10.1093/sleep/zsy061.396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - P Cheng
- Henry Ford Health Systems, Novi, MI
| | | | - C Tonnu
- Henry Ford Health Systems, Novi, MI
| | - K Moss
- Henry Ford Health Systems, Novi, MI
| | - T Arnedt
- University of Michigan, Ann Arbor, MI
| | - C Drake
- Henry Ford Health Systems, Novi, MI
| |
Collapse
|
49
|
Goldschmied J, Cheng P, Armitage R, Deldin P. 0245 Examining the Effects of Slow-wave Activity Disruption on Waking EEG Theta Activity. Sleep 2018. [DOI: 10.1093/sleep/zsy061.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- J Goldschmied
- Center for Sleep and Circadian Neurobiology, University of Pennsylvania, Philadelphia, PA
| | - P Cheng
- Sleep Disorders and Research Center, Henry Ford Health System, Detroit, MI
| | | | - P Deldin
- Department of Psychology, University of Michigan, Ann Arbor, MI
| |
Collapse
|
50
|
Cuamatzi-Castelan AS, Cheng P, Fellman-Couture C, Tallent G, Tran KM, Espie CA, Joseph C, Roehrs T, Drake CL. 0375 Long-term Efficacy of the Sleep to Prevent Evolving Affective Disorders (SPREAD) Trial as an Internet-based Treatment for Insomnia. Sleep 2018. [DOI: 10.1093/sleep/zsy061.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - P Cheng
- Henry Ford Health Systems, Novi, MI
| | | | | | - K M Tran
- Henry Ford Health Systems, Novi, MI
| | | | - C Joseph
- Henry Ford Health Systems, Novi, MI
| | - T Roehrs
- Henry Ford Health Systems, Detroit, MI
| | | |
Collapse
|